FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,N,O,S,P,F,Cl,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature0342,NA,C8 H16 N2 O9,284.08565,NA,NA,Feature0342,8,16,2,9,0,0,0,0,2,1.125,1,31.799999999999997,2,-7,3,-3,-9,Carbohydrate,798906.35699915,10623737.251440769,13.297850440626888,3.733121151946092,0.023590592091947263,0.042020742163781065,Upregulated
Feature0341,3-Deoxytetronic acid,C4 H8 O4,120.04228,NA,NA,3-Deoxytetronic acid,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,4254231.975575859,5696095.896561941,1.338924611836878,0.42107473199086676,0.37127119508707285,0.4226689811650662,Upregulated
Feature0340,6-Deoxy-D-arabino-hexos-2-ulose,C6 H10 O5,162.05281,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,6-Deoxy-D-arabino-hexos-2-ulose,6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,704602.158162424,1423046.8018390716,2.0196458176488195,1.0141023118267447,0.14914807300874852,0.20161518169562054,Upregulated
Feature0339,Oleic acid,C18 H34 O2,282.2559,Biosynthesis of plant secondary metabolites;Other,Other,Oleic acid,18,34,0,2,0,0,0,0,1.8888888888888888,0.1111111111111111,-1.666666666666667,107.8,2,0,0,0.0588235294117647,0,Lipid,115283.96715430982,4696677.310620585,40.740073633430676,5.3483766827142185,0.0017497211630990103,0.004274318841284725,Upregulated
Feature0338,DL-TYROSINE,C9 H11 N O3,181.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Central carbon metabolism in cancer;Other,Superpathway of chorismate metabolism;Superpathway of betalain biosynthesis;Other,DL-TYROSINE,9,11,1,3,0,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,710245.4070353217,5299561.226223765,7.461591688913532,2.899483415569232,1.1936074559552773e-9,1.4640186925060366e-7,Upregulated
Feature0337,Mevalonic acid,C6 H12 O4,148.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Biosynthesis of terpenoids and steroids;Other,Superpathway of branched chain amino acid biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Mevalonic acid-peak2,6,12,0,4,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,350810.1010018032,3278487.8143344824,9.345477239601008,3.2242683390507443,0.06582640201320579,0.1032689426078733,Upregulated
Feature0336,MFCD01318772,C8 H13 N3 O2,183.10073,NA,NA,MFCD01318772,8,13,3,2,0,0,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,3570648.161759712,3077735.383304178,0.8619542570073291,-0.2143167858279133,0.0903465827259321,0.13375987572410727,Downregulated
Feature0335,Leu-arg,C12 H25 N5 O3,287.19584,NA,NA,Leu-arg,12,25,5,3,0,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,1284053.1962564404,1088099.2098138921,0.8473941835012465,-0.2388948687849293,0.37199813839381557,0.4226689811650662,Downregulated
Feature0334,Ser-Leu,C9 H18 N2 O4,218.12657,Other,NA,Ser-Leu,9,18,2,4,0,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,6606906.071100693,5355930.892336704,0.8106564305135369,-0.302837488724929,0.33121052177319765,0.38925772662004676,Downregulated
Feature0333,beta-D-Ethyl glucuronide,C8 H14 O7,222.07387,NA,NA,beta-D-Ethyl glucuronide-peak5,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,129513719.21263121,145792.2657313147,0.0011256897463654636,-9.794975026565846,8.451191039598741e-9,2.6275521232206993e-7,Downregulated
Feature0332,NA,C8 H11 N O5,201.06375,NA,NA,Feature0332,8,11,1,5,0,0,0,0,1.375,0.625,0.25,53.175,4,-1,-1,0.1111111111111111,-2,Lignin,6150482.508503071,3543949.9928493453,0.5762068240906006,-0.795341348267799,0.030861347930991018,0.05277290496199464,Downregulated
Feature0331,NA,C9 H13 N O4 S,231.05648,NA,NA,Feature0331,9,13,1,4,1,0,0,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,6584512.150637949,5740894.7229748815,0.8718785221496884,-0.19780095495480557,0.35054802564501153,0.4063392334824771,Downregulated
Feature0330,"8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol",C7 H13 N O4,175.08438,NA,NA,"8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol",7,13,1,4,0,0,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,457038.6321235587,1936182.0601262124,4.236364114626469,2.082826594002178,6.262350320149328e-6,3.63004035506961e-5,Upregulated
Feature0329,NA,C21 H36 N2 O6 S4,540.14577,NA,NA,Feature0329,21,36,2,6,4,0,0,0,1.7142857142857142,0.2857142857142857,-0.4761904761904763,73.87142857142857,5,-1,-0.7777777777777778,-0.3333333333333333,-7,Lipid,16909456.704174217,1089815.1479123035,0.06445003922824291,-3.955674953074931,0.06820464031920831,0.10543231596123027,Downregulated
Feature0328,3-methoxyanthranilic acid,C8 H9 N O3,167.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,3-methoxyanthranilic acid,8,9,1,3,0,0,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,1542870.1361497454,2056089.86143096,1.332639613183493,0.4142866839760585,0.1906576702810543,0.2507881662927714,Upregulated
Feature0327,cis-trihomoaconitic acid,C9 H12 O6,216.0633,Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Other,NA,cis-trihomoaconitic acid-peak2,9,12,0,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,4,-2,-0.6666666666666666,0.16666666666666666,-2,Tannin,2608731.8013422475,942168.0862148645,0.36115942839739185,-1.4692922611423547,1.8827717018509273e-6,1.314097800067382e-5,Downregulated
Feature0326,asp-leu,C10 H18 N2 O5,246.12159,Metabolic pathways;Other,NA,asp-leu-peak2,10,18,2,5,0,0,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,802316.0467605197,198580.27681178792,0.24750879359024136,-2.014448312144953,0.16153303955478365,0.21495836392115178,Downregulated
Feature0325,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05284,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak3",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,6985277.655401945,4953154.03401737,0.7090847749175629,-0.4959699751210262,0.02012818948249587,0.037209950286559934,Downregulated
Feature0324,NA,C13 H11 N7 O4 S,361.05925,NA,NA,Feature0324,13,11,7,4,1,0,0,0,0.8461538461538461,0.3076923076923077,1.5384615384615383,16.453846153846158,12,8,0,0.6666666666666666,0,Lignin,270320.80954925733,2430496.634927544,8.99115624498255,3.16850665541047,0.0014814904668469402,0.0036983192676033104,Upregulated
Feature0323,4-Undecylbenzenesulfonic acid,C17 H28 O3 S,312.17604,NA,NA,4-Undecylbenzenesulfonic acid-peak2,17,28,0,3,1,0,0,0,1.6470588235294117,0.17647058823529413,-1.1764705882352944,93.8294117647059,4,1,0,0.10344827586206896,0,Lipid,506766.6452239235,3981645.0234681517,7.856959531558739,2.973971129612939,9.772131436869488e-4,0.0025907511251235388,Upregulated
Feature0322,Genipin,C11 H14 O5,226.0841,NA,NA,Genipin,11,14,0,5,0,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,283477.0286265265,273250.3577286245,0.9639241636352293,-0.053008447447796175,0.871450187938439,0.884379715949395,Downregulated
Feature0321,Ro 20-1724,C15 H22 N2 O3,278.16312,NA,NA,Ro 20-1724,15,22,2,3,0,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,5014541.450965178,4866569.4395702835,0.970491417242864,-0.0432126406871249,0.9055816226401747,0.9135956193007072,Downregulated
Feature0320,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.074,NA,NA,Phenyl D-glucopyranosiduronic acid,12,14,0,7,0,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,3903019.7203978715,5570128.387702725,1.4271330371692075,0.51311982893985,0.014315267101419626,0.027048736733069127,Upregulated
Feature0319,NA,C6 H12 O8 S,244.02539,NA,NA,Feature0319,6,12,0,8,1,0,0,0,2,1.3333333333333333,1,31.799999999999997,1,-7,2.6666666666666665,-4,-8,Carbohydrate,9924559.478169026,2062902.3378264005,0.20785832785466704,-2.2663275441156263,3.7189653527098614e-5,1.630623270034324e-4,Downregulated
Feature0318,NA,C7 H16 O6,196.09468,NA,NA,Feature0318,7,16,0,6,0,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,381780.43738795206,1955009.23926519,5.1207685041194955,2.3563603402803652,0.09625914250067322,0.14129024349884223,Upregulated
Feature0317,"2,2-Bis(hydroxymethyl)propionic acid",C5 H10 O4,134.05797,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,"2,2-Bis(hydroxymethyl)propionic acid",5,10,0,4,0,0,0,0,2,0.8,-0.4000000000000003,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,2026604.0020887367,5010894.3017827915,2.4725571925340475,1.306003892240587,3.344662397811684e-6,2.1997587308684534e-5,Upregulated
Feature0316,Adipic acid,C6 H10 O4,146.05797,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,0,4,0,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,464018.33790152945,3034985.9088472095,6.540659411377125,2.70943609162043,2.1835212507233286e-4,7.778794455701858e-4,Upregulated
Feature0315,D-(+)-Mannose,C6 H12 O6,180.06334,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of scopolin and esculin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of betalain biosynthesis;Other,D-(+)-Mannose,6,12,0,6,0,0,0,0,2,1,0,60.3,1,-5,-Inf,-0.6666666666666666,-5,Carbohydrate,12397832.770177837,399735.6409124318,0.03224238044845784,-4.95489792809226,9.787786182801314e-7,8.583135575687306e-6,Downregulated
Feature0314,N-(2-Hydroxyethyl)glutamine,C7 H14 N2 O4,190.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,N-(2-Hydroxyethyl)glutamine,7,14,2,4,0,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,2459242.007121964,4710978.922825042,1.9156223377699506,0.9378131638239692,0.0020262799766882153,0.0048460681959955915,Upregulated
Feature0313,Glycyl-L-leucine,C8 H16 N2 O3,188.11609,Metabolic pathways;Other,Superpathway of L-lysine degradation,Glycyl-L-leucine,8,16,2,3,0,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,3166300.4590552417,3266412.9032264166,1.0316181125151485,0.04490900841268714,0.886372961717357,0.8968625825660832,Upregulated
Feature0312,NA,C12 H9 N5 O7 S,367.02222,NA,NA,Feature0312,12,9,5,7,1,0,0,0,0.75,0.5833333333333334,1.8333333333333337,8.04999999999999,11,4,2,0.6,-2,Condensed HC,2198641.8581087887,5789628.727462743,2.633275040275465,1.3968582158459186,1.1410824737982333e-4,4.645835786178521e-4,Upregulated
Feature0311,NA,C28 H43 O4 P,474.28996,NA,NA,Feature0311,28,43,0,4,0,1,0,0,1.5357142857142858,0.14285714285714285,-1.4285714285714288,101.01428571428572,8,4,0.13043478260869565,0.2,3,Lipid,2211201.715272377,7774169.367298493,3.515811928691846,1.8138578984674965,8.245250365570147e-4,0.002220374507893693,Upregulated
Feature0310,NA,C8 H11 O4 P S,234.01153,NA,NA,Feature0310,8,11,0,4,1,1,0,0,1.375,0.5,-0.75,81.675,4,0,-1,0,-2,Lignin,2572030.568759425,444132.045330917,0.1726775920649872,-2.533847214766202,0.26918861977415237,0.33599455460861355,Downregulated
Feature0309,(E)-Ferulic acid,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Other,(E)-Ferulic acid,10,10,0,4,0,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,395698.0111767797,1498330.0185899495,3.786549278157894,1.9208837040674522,0.012934912321780564,0.02471363136340197,Upregulated
Feature0308,3-Hydroxybutyric acid,C4 H8 O3,104.04735,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak3,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,764326.8370705002,4010155.3447500444,5.246649928085875,2.391396532335744,0.0649702945510747,0.10239557943072602,Upregulated
Feature0307,"2,4-Dihydroxybenzoic acid",C7 H6 O4,154.02667,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,"2,4-Dihydroxybenzoic acid",7,6,0,4,0,0,0,0,0.8571428571428571,0.5714285714285714,0.2857142857142856,52.15714285714286,5,1,0.3333333333333333,0.6,1,Lignin,11068028.230703542,8268824.815053027,0.7470910484411926,-0.42064401903469884,6.876918693770144e-4,0.0019599218277244913,Downregulated
Feature0306,NA,C12 H17 N O4,239.11571,NA,NA,Feature0306,12,17,1,4,0,0,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,7749667.032912102,8787945.11895191,1.1339771220660628,0.18139153427063495,0.4688939516674778,0.5163145307724273,Upregulated
Feature0305,6-Deoxy-3-O-methyl-beta-D-galactopyranose,C7 H14 O5,178.08407,NA,NA,6-Deoxy-3-O-methyl-beta-D-galactopyranose-peak2,7,14,0,5,0,0,0,0,2,0.7142857142857143,-0.5714285714285712,76.58571428571427,1,-4,-2,-0.3333333333333333,-4,Carbohydrate,545431.9312996583,227176.3608297953,0.4165072629475106,-1.2635864417287195,9.010429706071875e-7,8.109386735464687e-6,Downregulated
Feature0304,NA,C6 H7 N3 O5 P2,262.98597,NA,NA,Feature0304,6,7,3,5,0,2,0,0,1.1666666666666667,0.8333333333333334,0.3333333333333335,50.8,6,1,1,1,-4,Tannin,21881153.48683566,337327.9477323988,0.015416369522536605,-6.019393131947639,5.1231995214421424e-9,2.00941174471851e-7,Downregulated
Feature0303,diphthinate,C13 H22 N4 O4,298.16421,NA,NA,diphthinate,13,22,4,4,0,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,1491549.5436199703,131022.81954036288,0.08784342437755858,-3.5089218941266633,0.12628363431277276,0.17773252236612463,Downregulated
Feature0302,NA,C3 H9 N4 O2 P,164.04635,NA,NA,Feature0302,3,9,4,2,0,1,0,0,3,0.6666666666666666,0.6666666666666665,41.3,2,0,1.25,1.3333333333333333,-5,Other,221408.9493204012,1310660.9667442385,5.91963861789335,2.5655091048935956,0.06635590172150949,0.10362428488016551,Upregulated
Feature0301,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05281,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak2",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,9957244.174919853,3089431.7553900345,0.3102697594954682,-1.6884050037311729,0.01394944764529227,0.026503950526055312,Downregulated
Feature0300,DL-Nordihydroguaiaretic acid,C18 H22 O4,302.1519,NA,NA,DL-Nordihydroguaiaretic acid,18,22,0,4,0,0,0,0,1.2222222222222223,0.2222222222222222,-0.7777777777777777,82.46666666666667,8,4,0.2857142857142857,0.375,4,Lignin,63755.27873352452,514381.1199251879,8.068055385266636,3.0122209877405686,0.12278176218251328,0.1742380193627367,Upregulated
Feature0299,N-Acetyl-Î±-D-glucosamine 1-phosphate,C8 H16 N O9 P,301.05637,Metabolic pathways;Galactose metabolism;Phosphotransferase system (PTS);Other,Chitin biosynthesis;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,N-Acetyl-Î±-D-glucosamine 1-phosphate,8,16,1,9,0,1,0,0,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,873245.821922512,5033644.866749053,5.764293100958823,2.527143695080493,4.6311115542940404e-4,0.0014530643592372127,Upregulated
Feature0298,3-O-methylgallic acid,C8 H8 O5,184.03711,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,3-O-methylgallic acid,8,8,0,5,0,0,0,0,1,0.625,0.25,53.175,5,0,0,0.4545454545454546,0,Lignin,372622.9319120885,4110104.9297983693,11.030198567510737,3.4633868576919475,0.011757441886980413,0.022846847303109666,Upregulated
Feature0297,Wikstromol,C20 H22 O7,374.13667,NA,NA,Wikstromol,20,22,0,7,0,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,156093.9504675253,237190.7000980629,1.5195380691413112,0.6036328192981076,0.12519626117773996,0.17693025339994656,Upregulated
Feature0296,Propyl gallate,C10 H12 O5,212.06837,NA,NA,Propyl gallate,10,12,0,5,0,0,0,0,1.2,0.5,-0.20000000000000015,66,5,0,0,0.3333333333333333,0,Lignin,657752.721073678,375985.39569819986,0.5716211938803731,-0.8068686869573614,0.02807892711880593,0.048499965023392065,Downregulated
Feature0295,D-Sedoheptulose 7-phosphate,C7 H15 O10 P,290.04036,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;Other,Other,D-Sedoheptulose 7-phosphate,7,15,0,10,0,1,0,0,2.142857142857143,1.4285714285714286,0,60.3,1,-9,2.5,-5,-10,Carbohydrate,1000710.7073594714,1745166.2408420604,1.7439268192172632,0.8023395012573286,0.18534530669757168,0.24474167911416803,Upregulated
Feature0294,Acetyl-L-methionine,C7 H13 N O3 S,191.06167,NA,NA,Acetyl-L-methionine,7,13,1,3,1,0,0,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,332299.8766504108,3285820.6289054267,9.88811871381525,3.3056960639142585,7.347221140035496e-4,0.0020264109918485,Upregulated
Feature0293,Dodecyl sulfate,C12 H26 O4 S,266.15528,NA,NA,Dodecyl sulfate-peak2,12,26,0,4,1,0,0,0,2.1666666666666665,0.3333333333333333,-1.333333333333333,98.29999999999998,0,-4,-0.7142857142857143,-0.3333333333333333,-5,Protein,582768.3562988346,5100874.548008506,8.752833768127344,3.1297501713856963,3.069208144357766e-4,0.0010091685631010289,Upregulated
Feature0292,Glycolic acid,C2 H4 O3,76.01607,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Other,Glycolic acid-peak2,2,4,0,3,0,0,0,0,2,1.5,1,31.799999999999997,1,-2,2,-1,-2,Carbohydrate,20767024.524767436,3607894.044601724,0.17373187190581063,-2.525065647560726,1.1600468970393573e-5,5.7497976635863797e-5,Downregulated
Feature0291,NA,C12 H22 N6 O7 P2 S2,488.04681,NA,NA,Feature0291,12,22,6,7,2,2,0,0,1.8333333333333333,0.5833333333333334,0.3333333333333335,50.8,6,-1,2.2,5,-11,Amino Sugar,2149557.6620468935,2519250.0452228393,1.1719853296812286,0.22895451094735852,0.7142154288301091,0.7469776044645178,Upregulated
Feature0290,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00407,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak3,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,324256.0581212494,280444.4135997028,0.8648856561835953,-0.2094186837114567,0.3982839528747617,0.44660036683006066,Downregulated
Feature0289,NA,C23 H51 N6 O15 P S3,778.23108,NA,NA,Feature0289,23,51,6,15,3,1,0,0,2.217391304347826,0.6521739130434783,-0.08695652173913082,62.77826086956522,2,-13,11.5,-2.8181818181818183,-23,Other,233681.11852595228,281531.565290997,1.204768134742262,0.26875551737241976,0.5273978477756898,0.5726033775850345,Upregulated
Feature0288,"N'-(2-Thienylcarbonyl)-2,5-bis(2,2,2-trifluoroethoxy)benzohydrazide",C16 H12 F6 N2 O4 S,442.04207,NA,NA,"N'-(2-Thienylcarbonyl)-2,5-bis(2,2,2-trifluoroethoxy)benzohydrazide",16,12,2,4,1,0,6,0,0.75,0.25,0.25,53.175,12,8,0.5555555555555556,0.6363636363636364,5,Condensed HC,7717707.063005382,206088.94513808202,0.026703390457246526,-5.226833261145823,0.010819648852758644,0.021389132414124025,Downregulated
Feature0287,"(1S,2S,3R,4S,5R,6S)-2,3,4,6-Tetrahydroxy-5-methoxycyclohexyl 6-O-alpha-D-galactopyranosyl-alpha-D-galactopyranoside",C19 H34 O16,518.18462,NA,NA,"(1S,2S,3R,4S,5R,6S)-2,3,4,6-Tetrahydroxy-5-methoxycyclohexyl 6-O-alpha-D-galactopyranosyl-alpha-D-galactopyranoside",19,34,0,16,0,0,0,0,1.7894736842105263,0.8421052631578947,-0.10526315789473716,63.3,3,-13,-4.333333333333333,-0.4545454545454546,-13,Carbohydrate,1241494.8265155607,195617.34956927024,0.15756598045462608,-2.665972013946843,3.142837497107036e-5,1.40963054247593e-4,Downregulated
Feature0286,(-)-Shikimic acid,C7 H10 O5,174.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,(-)-Shikimic acid-peak2,7,10,0,5,0,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,737425.6886028363,4975302.715439538,6.746852994592574,2.754214727676106,2.53713995821514e-4,8.775758880940929e-4,Upregulated
Feature0285,"2,3-Dihydroxypropyl beta-D-galactopyranoside",C9 H18 O8,254.10022,Galactose metabolism;Other,NA,"2,3-Dihydroxypropyl beta-D-galactopyranoside",9,18,0,8,0,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,7891808.395257345,4984353.288028149,0.6315856947342439,-0.6629496000186735,0.012482811531637389,0.023983828897865093,Downregulated
Feature0284,NA,C31 H27 N2 O10 P,618.14042,NA,NA,Feature0284,31,27,2,10,0,1,0,0,0.8709677419354839,0.3225806451612903,-0.193548387096774,65.81612903225806,20,10,0.3888888888888889,0.5217391304347826,7,Lignin,78851.70881674446,52257.82503001211,0.662735479220394,-0.5934949394307791,0.00477545908597651,0.010536819402606236,Downregulated
Feature0283,NA,C2 H5 N O4 S4,234.91002,NA,NA,Feature0283,2,5,1,4,4,0,0,0,2.5,2,7,-139.2,1,-3,1.1428571428571428,1.2,-8,Other,390751.6530337287,2262197.488767875,5.789348480561918,2.5334009998984675,0.2688285726280559,0.33599455460861355,Upregulated
Feature0282,D-Glucono-delta-lactone,C6 H10 O6,178.04779,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucono-delta-lactone-peak2,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,1015610.5652284116,1666657.7820933885,1.6410402167474065,0.7146105952142632,0.25286331111067034,0.3202935274068491,Upregulated
Feature0281,NA,C12 H10 N2 O7 S,326.02086,NA,NA,Feature0281,12,10,2,7,1,0,0,0,0.8333333333333334,0.5833333333333334,1,31.799999999999997,9,2,-0.5,0.4545454545454546,-1,Lignin,772082.6022906553,2162901.696617485,2.801386393373552,1.486140987110343,0.031237759176857866,0.053142508685136924,Upregulated
Feature0280,NA,C17 H33 N O8 S2,443.16496,NA,NA,Feature0280,17,33,1,8,2,0,0,0,1.9411764705882353,0.4705882352941176,-0.5882352941176467,77.06470588235292,2,-6,-1.5,-0.5,-9,Protein,15233925.774290126,184980.4019118096,0.012142661363362811,-6.363771531366437,1.9871910752478336e-9,1.4640186925060366e-7,Downregulated
Feature0279,NA,C16 H28 O14,444.14812,NA,NA,Feature0279,16,28,0,14,0,0,0,0,1.75,0.875,0,60.3,3,-11,-5.5,-0.4444444444444444,-11,Carbohydrate,1612857.6114478004,183906.5076125448,0.11402525945700749,-3.132574641929913,0.024750735675272344,0.043408982568939186,Downregulated
Feature0278,Phloroacetophenone,C8 H8 O4,168.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Phloroacetophenone,8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,2990769.8673999943,4878155.497126463,1.6310701636723572,0.7058188437327759,0.024128341371609227,0.042755920979742776,Upregulated
Feature0277,Dodecyl sulfate,C12 H26 O4 S,266.15522,NA,NA,Dodecyl sulfate-peak1,12,26,0,4,1,0,0,0,2.1666666666666665,0.3333333333333333,-1.333333333333333,98.29999999999998,0,-4,-0.7142857142857143,-0.3333333333333333,-5,Protein,7539872.435399502,4879461.444840935,0.6471543765027101,-0.6278181915591682,0.1362777402459,0.19031789957596618,Downregulated
Feature0276,2-(Benzoyloxy)-3-hydroxysuccinic acid,C11 H10 O7,254.04268,NA,NA,2-(Benzoyloxy)-3-hydroxysuccinic acid,11,10,0,7,0,0,0,0,0.9090909090909092,0.6363636363636364,0.36363636363636376,49.93636363636363,7,0,0,0.4666666666666667,0,Lignin,601012.2281928384,464298.8907460301,0.7725281932151586,-0.37234051012991043,0.13884951074428067,0.19147795433283868,Downregulated
Feature0275,trans-Aconitic acid,C6 H6 O6,174.01637,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Other,Superpathway of betalain biosynthesis;Other,trans-Aconitic acid,6,6,0,6,0,0,0,0,1,1,1,31.799999999999997,4,-2,-Inf,0.3333333333333333,-2,Tannin,354246.2788362297,150871.45496406883,0.425894254866168,-1.231432826215342,0.15529278676091163,0.20746145731340537,Downregulated
Feature0274,NA,C50 H80 O5 P2 S,854.52014,NA,NA,Feature0274,50,80,0,5,1,2,0,0,1.6,0.1,-1.5599999999999996,104.76,12,7,0.09523809523809525,0.14606741573033707,4,Lipid,65526.09688079127,1015291.7030437959,15.494463295912027,3.9536808779666206,0.005860541472389123,0.012309344524772392,Upregulated
Feature0273,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak2,11,21,3,4,0,0,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,2378885.1176147107,1811685.9972836752,0.7615693519072659,-0.39295267393725813,0.38382757756572694,0.43435878571505776,Downregulated
Feature0272,"N-acetyl-LL-2,6-diaminopimelic acid",C9 H16 N2 O5,232.10586,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,"N-acetyl-LL-2,6-diaminopimelic acid",9,16,2,5,0,0,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,4522895.550300924,1283297.102005205,0.28373352595326295,-1.8173914653577985,3.7991934608911473e-7,4.063009023516778e-6,Downregulated
Feature0271,NA,C11 H9 N S,187.04563,NA,NA,Feature0271,11,9,1,0,1,0,0,0,0.8181818181818182,0,-0.3636363636363633,70.66363636363636,8,8,0.6666666666666666,0.6666666666666666,6,Unsaturated HC,4305383.531568223,3876137.816058294,0.9003002375136653,-0.15152189462382712,0.5166593007786583,0.5645286928635819,Downregulated
Feature0270,leu-gln,C11 H21 N3 O4,259.15324,NA,NA,leu-gln-peak1,11,21,3,4,0,0,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1836536.0051292744,3325244.180991703,1.8106065831024305,0.8564731049485349,0.011208891510683697,0.02203126952099899,Upregulated
Feature0269,Gly-Phe,C11 H14 N2 O3,222.10048,NA,NA,Gly-Phe,11,14,2,3,0,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,2648651.0366847254,1386141.6472982483,0.5233387215226585,-0.9341830878322768,7.662520494836733e-4,0.002079826991455685,Downregulated
Feature0268,3-formylsalicylic acid,C8 H6 O4,166.02653,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate,3-formylsalicylic acid,8,6,0,4,0,0,0,0,0.75,0.5,0.25,53.175,6,2,0.5,0.6666666666666666,2,Condensed HC,2243227.1465111407,2090983.2550227272,0.9321317541448282,-0.1013942047964098,0.7813981702590236,0.8001142940975631,Downregulated
Feature0267,NA,C9 H22 N O8 P,303.10844,NA,NA,Feature0267,9,22,1,8,0,1,0,0,2.4444444444444446,0.8888888888888888,-0.8888888888888893,85.63333333333334,0,-8,10,-2,-10,Carbohydrate,30767895.32210416,42975814.37577402,1.3967745900675725,0.48209921900772107,0.03672264557546174,0.060966722266057836,Upregulated
Feature0266,Gly-thr,C6 H12 N2 O4,176.0797,Other,NA,Gly-thr,6,12,2,4,0,0,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,1920027.829985683,1308760.4202330355,0.6816361720354827,-0.5529261985378978,0.08548005865825403,0.12822008798738105,Downregulated
Feature0265,NA,C9 H24 N6 O P2,294.14866,NA,NA,Feature0265,9,24,6,1,0,2,0,0,2.6666666666666665,0.1111111111111111,-1.5555555555555554,104.63333333333333,2,1,-Inf,-13,-7,Other,191378.28996619815,647981.4489457931,3.3858670649645877,1.7595253316265844,0.0014716686065724908,0.0036983192676033104,Upregulated
Feature0264,NA,C7 H17 N O10,275.08534,NA,NA,Feature0264,7,17,1,10,0,0,0,0,2.4285714285714284,1.4285714285714286,0.8571428571428572,35.87142857142857,0,-10,2.75,-6,-11,Carbohydrate,140273.44040475498,701412.4322716442,5.000322443420072,2.322021129392179,0.024582818596167812,0.04333672144272882,Upregulated
Feature0263,D-Glucosamine 6-phosphate,C6 H14 N O8 P,259.04576,Metabolic pathways;Biosynthesis of secondary metabolites;Galactose metabolism;Phosphotransferase system (PTS);Other,Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,D-Glucosamine 6-phosphate,6,14,1,8,0,1,0,0,2.3333333333333335,1.3333333333333333,0,60.3,1,-7,2.25,-Inf,-9,Carbohydrate,654347.5988259165,3452410.549330471,5.276110977598246,2.3994749105232684,2.2381738780395283e-5,1.0206072883860248e-4,Upregulated
Feature0262,Luteolin,C15 H10 O6,286.04782,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Other,Luteolin,15,10,0,6,0,0,0,0,0.6666666666666666,0.4,0.1333333333333333,56.5,11,5,0.5555555555555556,0.6666666666666666,5,Condensed HC,131085.46614287153,542274.7754691534,4.1368031973744674,2.048516325007065,0.1982872358538501,0.25982465387745873,Upregulated
Feature0261,NA,C7 H7 N3 O4 P2,258.99119,NA,NA,Feature0261,7,7,3,4,0,2,0,0,1,0.5714285714285714,0,60.3,7,3,1,NA,-2,Lignin,351900.28854630596,1616292.3119961284,4.593040598724724,2.199449535860177,0.005867724747968425,0.012309344524772392,Upregulated
Feature0260,Abietin,C16 H22 O8,342.13151,Biosynthesis of secondary metabolites;Other,NA,Abietin,16,22,0,8,0,0,0,0,1.375,0.5,-0.375,70.9875,6,-2,-0.25,0.16666666666666666,-2,Lignin,415274.6132556767,119543.86351857388,0.2878670154704906,-1.796525604156708,0.23089838196190426,0.29575747801861896,Downregulated
Feature0259,2-Aminomuconic acid,C6 H7 N O4,157.03757,Metabolic pathways;Other,Other,2-Aminomuconic acid,6,7,1,4,0,0,0,0,1.1666666666666667,0.6666666666666666,0.6666666666666665,41.3,4,0,-1,0.3333333333333333,-1,Tannin,5560001.358577008,1925963.6426837456,0.34639625397081997,-1.5295047664593966,7.046616331442293e-6,3.887004492505265e-5,Downregulated
Feature0258,3653579,C18 H24 O5,320.16251,NA,NA,3653579,18,24,0,5,0,0,0,0,1.3333333333333333,0.2777777777777778,-0.7777777777777777,82.46666666666667,7,2,0.15384615384615383,0.2903225806451613,2,Lignin,145748.4997271236,563823.9150545151,3.8684714841671077,1.951763639286482,0.11854149349702421,0.1689216282332595,Upregulated
Feature0257,"2-Hydroxy-3,4,5-trimethoxybenzoic acid",C10 H12 O6,228.06339,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"2-Hydroxy-3,4,5-trimethoxybenzoic acid",10,12,0,6,0,0,0,0,1.2,0.6,0,60.3,5,-1,-0.25,0.2857142857142857,-1,Lignin,1406089.1971158686,650528.3213286569,0.4626508209173377,-1.112004344135223,0.0415397196117322,0.06830088513082891,Downregulated
Feature0256,NA,C14 H22 O10,350.12144,NA,NA,Feature0256,14,22,0,10,0,0,0,0,1.5714285714285714,0.7142857142857143,-0.14285714285714324,64.37142857142858,4,-6,-1.5,-0.1111111111111111,-6,Carbohydrate,243288.4110543425,1313977.4059488482,5.4009042200343425,2.4332009636746985,0.004860858450018645,0.010588621591760359,Upregulated
Feature0255,Troxipide,C15 H22 N2 O4,294.1581,NA,NA,Troxipide,15,22,2,4,0,0,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,2297011.8688845034,2936391.436998394,1.2783527489670274,0.3542859888394364,0.27960238473687293,0.34587821478734887,Upregulated
Feature0254,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10606,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,2,5,0,0,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,3689221.270129294,1339684.89792343,0.3631348731426128,-1.4614226109237323,3.33591194849351e-4,0.001066244753630636,Downregulated
Feature0253,NA,C11 H20 N4 O3,256.15361,NA,NA,Feature0253,11,20,4,3,0,0,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,437492.3332546913,148742.57415194967,0.3399889845963482,-1.5564400900704494,0.10636790993887603,0.15284800503821683,Downregulated
Feature0252,MFCD00037215,C8 H14 N2 O5,218.09029,NA,NA,MFCD00037215,8,14,2,5,0,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,4435692.711087191,1280912.4352635632,0.2887739342407267,-1.7919875695555165,3.659893700548779e-7,4.063009023516778e-6,Downregulated
Feature0251,N-Acetyl-4-aminosalicylic acid,C9 H9 N O4,195.05319,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of betalain biosynthesis,N-Acetyl-4-aminosalicylic acid,9,9,1,4,0,0,0,0,1,0.4444444444444444,0.22222222222222232,53.96666666666666,6,2,0.25,0.5,1,Lignin,563590.6031469252,2863969.2956326576,5.0816484157845965,2.3452965630436795,1.728153455024591e-4,6.355144963638819e-4,Upregulated
Feature0250,NA,C12 H19 N O8,305.11118,NA,NA,Feature0250,12,19,1,8,0,0,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,137775.31944314326,1752435.1774438675,12.719514529357035,3.6689717026594035,1.931181353366347e-4,6.95225287211885e-4,Upregulated
Feature0249,"10,16-Dihydroxyhexadecanoic acid",C16 H32 O4,288.23015,Other,NA,"10,16-Dihydroxyhexadecanoic acid",16,32,0,4,0,0,0,0,2,0.25,-1.5,103.05,1,-3,-0.25,-0.07142857142857142,-3,Lipid,5831432.86725911,57868.094653304055,0.009923477809066028,-6.654938464596205,6.72415380021572e-8,1.0950764760351314e-6,Downregulated
Feature0248,"1-(3-Methoxyphenyl)-2,3-butanedione",C11 H12 O3,192.07867,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,"1-(3-Methoxyphenyl)-2,3-butanedione",11,12,0,3,0,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,355316.51606720267,186399.56114330378,0.5246014545185093,-0.9307062872392285,0.2801411271815662,0.34587821478734887,Downregulated
Feature0247,NA,C28 H41 N O6,487.29353,NA,NA,Feature0247,28,41,1,6,0,0,0,0,1.4642857142857142,0.21428571428571427,-0.9285714285714288,86.76428571428572,9,3,0.09523809523809525,0.20833333333333337,2,Lignin,77863.75957744033,1437499.691111902,18.46172980746222,4.206465830304932,0.021084318134827428,0.03815257567254487,Upregulated
Feature0246,"9-Hydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one",C14 H14 O5,262.08415,NA,NA,"9-Hydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one",14,14,0,5,0,0,0,0,1,0.35714285714285715,-0.2857142857142856,68.44285714285714,8,3,0.3333333333333333,0.4782608695652174,3,Lignin,601839.2422601928,82814.44427323811,0.1376022672802632,-2.861423853284534,0.29069044700773783,0.3550576174165941,Downregulated
Feature0245,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00421,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak2,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,79908.60763127214,89278.33040205183,1.1172554878445016,0.15995913112057403,0.39733312442746815,0.44660036683006066,Upregulated
Feature0244,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16783,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,1,3,0,0,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,66848.08110570391,890267.8771655239,13.317777600194429,3.7352814481160532,5.256459942475958e-4,0.0015673144905876803,Upregulated
Feature0243,NA,C7 H17 N8 O6 P,340.10075,Other,NA,Feature0243,7,17,8,6,0,1,0,0,2.4285714285714284,0.8571428571428571,2,3.299999999999997,4,-2,1.375,1.6,-11,Carbohydrate,3857967.9916928695,245704.80671363184,0.06368762188869717,-3.9728431873885097,5.287925643996079e-9,2.00941174471851e-7,Downregulated
Feature0242,NA,C4 H10 N6 P2,204.04415,NA,NA,Feature0242,4,10,6,0,0,2,0,0,2.5,0,-0.5,74.55,4,4,1,1,-4,Lipid,5685450.074508821,3581625.6836528247,0.629963439431354,-0.6666599921186569,2.447697760297758e-4,8.630027154864259e-4,Downregulated
Feature0241,"(2E)-3-(4,5-Dihydroxy-2,3-dimethoxyphenyl)-2-propen-1-yl hydrogen sulfate",C11 H14 O8 S,306.04103,NA,NA,"(2E)-3-(4,5-Dihydroxy-2,3-dimethoxyphenyl)-2-propen-1-yl hydrogen sulfate",11,14,0,8,1,0,0,0,1.2727272727272727,0.7272727272727273,0.36363636363636376,49.93636363636363,5,-3,-2,0,-4,Tannin,70378.05172583206,64659.615485980816,0.9187468806023752,-0.12226064838800345,0.4869349772476378,0.5337556481368337,Downregulated
Feature0240,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine,8,15,3,4,0,0,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,2645364.6846314655,896571.1023290149,0.338921551171278,-1.5609767177899065,4.802015450826096e-6,2.8671511358608825e-5,Downregulated
Feature0239,Catechin,C15 H14 O6,290.07918,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,NA,Catechin,15,14,0,6,0,0,0,0,0.9333333333333332,0.4,-0.13333333333333375,64.10000000000001,9,3,0.3333333333333333,0.5,3,Lignin,767630.2255060578,1229151.3810290385,1.6012284823968783,0.6791791834956353,0.002121192575236068,0.0050378323661856616,Upregulated
Feature0238,NA,C30 H50 O6 S,538.3329,NA,NA,Feature0238,30,50,0,6,1,0,0,0,1.6666666666666667,0.2,-1.2000000000000002,94.5,6,0,-0.04347826086956521,0.07692307692307693,-1,Lipid,62600.51499506247,1265104.4749917851,20.209170405252554,4.336938194596431,0.022269299620965573,0.04008473931773803,Upregulated
Feature0237,MFCD00155202,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,MFCD00155202-peak2,10,12,0,4,0,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,370515.705329322,238321.519103239,0.6432157009145237,-0.6366254717115422,0.07441500383845802,0.11361576478907429,Downregulated
Feature0236,pseudouridine,C9 H12 N2 O6,244.06949,Metabolic pathways;ABC transporters;Other,Other,pseudouridine,9,12,2,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,1920978.4334294167,2141419.062709904,1.114754348848647,0.15672582786454553,0.3516854184526702,0.4063392334824771,Upregulated
Feature0235,"(6E,8R,10Z)-8-Hydroxy-3-oxo-6,10-hexadecadienoic acid",C16 H26 O4,282.18315,Other,NA,"(6E,8R,10Z)-8-Hydroxy-3-oxo-6,10-hexadecadienoic acid",16,26,0,4,0,0,0,0,1.625,0.25,-1.125,92.3625,4,0,0,0.14285714285714285,0,Lipid,96510.95500732404,622064.3487603404,6.4455309629164175,2.6882992082400627,0.004077312582472585,0.009054811059776782,Upregulated
Feature0234,"2,4,6-Trihydroxyacetophenone",C8 H8 O4,168.0422,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"2,4,6-Trihydroxyacetophenone-peak2",8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,8890585.327176897,2123836.3340785964,0.23888599635688962,-2.0656058102794455,0.021002367693690346,0.03815257567254487,Downregulated
Feature0233,NA,C12 H15 N3 O9 P2,407.02843,NA,NA,Feature0233,12,15,3,9,0,2,0,0,1.25,0.75,0.16666666666666652,55.55,8,-1,3,-0.6,-6,Tannin,176187.52113983728,2570324.072420151,14.588570494615933,3.86676661821393,6.605022887438014e-6,3.703143979514427e-5,Upregulated
Feature0232,cis-trihomoaconitic acid,C9 H12 O6,216.06335,Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Other,NA,cis-trihomoaconitic acid-peak1,9,12,0,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,4,-2,-0.6666666666666666,0.16666666666666666,-2,Tannin,3512773.1304414645,2740590.439616929,0.7801786047231885,-0.3581236598201836,0.10447134965466778,0.152640861122249,Downregulated
Feature0231,Pyrogallol,C6 H6 O3,126.03174,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,Pyrogallol,6,6,0,3,0,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,3129494.2635312295,3148418.7401412157,1.0060471357402754,0.008697900477116303,0.9814117702569571,0.9814117702569571,Upregulated
Feature0230,NA,C27 H37 N O7,487.25721,NA,NA,Feature0230,27,37,1,7,0,0,0,0,1.3703703703703705,0.25925925925925924,-0.7407407407407405,81.4111111111111,10,3,0.10526315789473684,0.24444444444444444,2,Lignin,84112.90669183143,1605694.8234815267,19.08975550404398,4.254726720135126,3.926144721551384e-6,2.48655832364921e-5,Upregulated
Feature0229,NA,C10 H20 O9,284.11082,NA,NA,Feature0229,10,20,0,9,0,0,0,0,2,0.9,-0.20000000000000015,66,1,-8,-8,-0.6363636363636364,-8,Carbohydrate,325361.76907577337,239266.37504186103,0.7353856469416307,-0.4434270762033837,0.6040007943365788,0.6536970622250315,Downregulated
Feature0228,5-Aminonicotinic acid,C6 H6 N2 O2,138.04298,Metabolic pathways;Other,NA,5-Aminonicotinic acid,6,6,2,2,0,0,0,0,1,0.3333333333333333,0.6666666666666665,41.3,5,3,0.5,0.6666666666666666,1,Lignin,3806814.000462996,1711124.4730398078,0.44948990752679163,-1.1536393718606763,0.0018357203607734353,0.004452598321875992,Downregulated
Feature0227,NA,C27 H37 N O6,471.26226,NA,NA,Feature0227,27,37,1,6,0,0,0,0,1.3703703703703705,0.2222222222222222,-0.8148148148148149,83.52222222222223,10,4,0.15,0.2608695652173913,3,Lignin,84612.0814351961,1136711.7492278428,13.434390573389258,3.7478589724951714,5.198417121519858e-5,2.2223233194497397e-4,Upregulated
Feature0226,2-[3-carboxylato-3-(methylammonio)propyl]-L-histidine dizwitterion,C11 H18 N4 O4,270.13292,NA,NA,2-[3-carboxylato-3-(methylammonio)propyl]-L-histidine dizwitterion,11,18,4,4,0,0,0,0,1.6363636363636365,0.3636363636363637,0.18181818181818168,55.11818181818182,5,1,-1,-0.2,-3,Protein,296248.2689990136,1459238.7622207748,4.925729244431918,2.3003373285167705,7.534724818833745e-4,0.002061500710432913,Upregulated
Feature0225,UNII:74D1OHC38H,C19 H32 O4,324.23021,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H,19,32,0,4,0,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,83147.54909911833,1136585.3605718687,13.66949925627959,3.7728884897176593,0.0027753736841248555,0.006413363513315545,Upregulated
Feature0224,val-phe,C14 H20 N2 O3,264.14747,Metabolic pathways;Other,NA,val-phe,14,20,2,3,0,0,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,3894622.8676481107,2533915.48855027,0.650618962261795,-0.6201152246103832,0.035502540229050465,0.059244643525602186,Downregulated
Feature0223,(-)-Shikimic acid,C7 H10 O5,174.05282,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,(-)-Shikimic acid-peak1,7,10,0,5,0,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,221118.34258686006,1665463.9302162612,7.5320025952258165,2.913033497047039,4.8375726834664945e-4,0.0014771873729870902,Upregulated
Feature0222,NP-008177,C28 H41 N O5,471.29858,NA,NA,NP-008177,28,41,1,5,0,0,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,132508.40917589676,2003499.5098196976,15.119791432709567,3.9183663335818677,0.01909757706595127,0.03549658345953986,Upregulated
Feature0221,D-(-)-Mannitol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,D-(-)-Mannitol,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,523645.83334284445,1812190.212840293,3.4607173349812665,1.7910711096413383,1.6780978420210963e-8,4.0966930653887634e-7,Upregulated
Feature0220,2271703,C10 H17 N O5,231.11056,NA,NA,2271703,10,17,1,5,0,0,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,239852.67754726598,1703368.6579006333,7.101728758333178,2.828170259474559,5.270209544373779e-4,0.0015673144905876803,Upregulated
Feature0219,2-Hydroxybenzyl alcohol,C7 H8 O2,124.05246,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,2-Hydroxybenzyl alcohol,7,8,0,2,0,0,0,0,1.1428571428571428,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,2,0.4,0.5,2,Lignin,271906.1456356727,430076.3523305646,1.5817088331163514,0.6614840475475509,0.21600755524461165,0.279827969294156,Upregulated
Feature0218,2'-Deoxyinosine,C10 H12 N4 O4,252.08587,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxyinosine,10,12,4,4,0,0,0,0,1.2,0.4,0.7999999999999998,37.5,7,3,-0.5,0.25,-1,Lignin,5310853.14015346,1681462.1078325696,0.3166086621977242,-1.6592273677169276,0.002821672856006035,0.006476591387611167,Downregulated
Feature0217,S-inosyl-L-homocysteine,C14 H19 N5 O6 S,385.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,S-inosyl-L-homocysteine,14,19,5,6,1,0,0,0,1.3571428571428572,0.42857142857142855,0.7142857142857144,39.942857142857136,8,2,-2,-0.2,-4,Lignin,614211.9674392759,187178.60101337644,0.3047459361525414,-1.71432111253791,1.8614140986922787e-9,1.4640186925060366e-7,Downregulated
Feature0216,asp-leu,C10 H18 N2 O5,246.12157,Metabolic pathways;Other,NA,asp-leu-peak1,10,18,2,5,0,0,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,1350325.5458057856,638870.5184407749,0.47312332972234405,-1.0797117929579116,1.7176636803694777e-6,1.2563630984216796e-5,Downregulated
Feature0215,lys-leu,C12 H25 N3 O3,259.18964,NA,NA,lys-leu,12,25,3,3,0,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,1949326.379095928,2074434.4127280337,1.0641801367763408,0.08974238057326682,0.6764477321993309,0.7184651905559911,Upregulated
Feature0214,2-Aminooctanedioic acid,C8 H15 N O4,189.10013,NA,NA,2-Aminooctanedioic acid-peak2,8,15,1,4,0,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,1749683.147290473,4167827.3264179225,2.3820469053909235,1.2522018218958213,0.02083906098478034,0.03815257567254487,Upregulated
Feature0213,beta-D-Xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose,C20 H34 O17,546.17964,ABC transporters,NA,beta-D-Xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose,20,34,0,17,0,0,0,0,1.7,0.85,0,60.3,4,-13,-4.333333333333333,-0.391304347826087,-13,Carbohydrate,9341899.834023805,513522.32082501275,0.05496979521817726,-4.185217084935533,4.913833776288059e-8,8.780511374237517e-7,Downregulated
Feature0212,N-Acetylalanine,C5 H9 N O3,131.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Other,N-Acetylalanine,5,9,1,3,0,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,4933358.826873069,2912921.570360448,0.5904540238372965,-0.7601033674652121,0.0017156072039062908,0.004251722200985155,Downregulated
Feature0211,Threonylleucine,C10 H20 N2 O4,232.14232,Other,NA,Threonylleucine,10,20,2,4,0,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,2167020.88003514,3246418.129570291,1.4981019146975858,0.5831357725466355,0.1432002275616836,0.19668464990399917,Upregulated
Feature0210,2-Hydroxy-3-[4-(sulfooxy)phenyl]propanoic acid,C9 H10 O7 S,262.01468,NA,NA,2-Hydroxy-3-[4-(sulfooxy)phenyl]propanoic acid,9,10,0,7,1,0,0,0,1.1111111111111112,0.7777777777777778,0.6666666666666665,41.3,5,-2,-3,0.1111111111111111,-3,Tannin,336539.10182787024,2301205.311066135,6.837854200499807,2.7735436613705473,7.8973825118857e-8,1.1743064430716998e-06,Upregulated
Feature0209,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid,C9 H12 O5,200.06848,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid-peak2,9,12,0,5,0,0,0,0,1.3333333333333333,0.5555555555555556,-0.22222222222222232,66.63333333333333,4,-1,-0.25,0.2307692307692308,-1,Lignin,1478834.8570971647,204796.29565045476,0.1384848988834721,-2.852199429036941,0.26260713787854917,0.33018985718552873,Downregulated
Feature0208,Loganetin,C11 H16 O5,228.09967,NA,NA,Loganetin,11,16,0,5,0,0,0,0,1.4545454545454546,0.4545454545454546,-0.5454545454545459,75.84545454545456,4,-1,-0.16666666666666666,0.17647058823529413,-1,Lignin,3005846.268754956,684056.1893035343,0.22757524109404156,-2.1355844858097246,0.1118294465251393,0.16002372682676838,Downregulated
Feature0207,3-Hydroxybutyric acid,C4 H8 O3,104.04737,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak2,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,1028643.6268570948,2070323.3010119193,2.01267304531654,1.0091128283887243,0.26144915503644744,0.3299469041419374,Upregulated
Feature0206,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09571,Other,NA,N-(2-Cyanoethyl)-L-glutamine,8,13,3,3,0,0,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,247359.2896094361,3033176.9212512136,12.262231695605202,3.6161496647137668,1.354438522040454e-4,5.324344534917647e-4,Upregulated
Feature0205,NA,C6 H3 N2 O4 P3,259.93046,NA,NA,Feature0205,6,3,2,4,0,3,0,0,0.5,0.6666666666666666,-0.666666666666667,79.30000000000001,8,4,0.3333333333333333,-1,-1,Condensed HC,2764718.79983943,1159123.4366076998,0.41925545436122463,-1.2540985420370288,0.15495383863079112,0.20746145731340537,Downregulated
Feature0204,Miglitol,C8 H17 N O5,207.11059,NA,NA,Miglitol,8,17,1,5,0,0,0,0,2.125,0.625,-0.5,74.55,1,-4,-2.5,-0.5555555555555556,-5,Amino Sugar,212866.82773698852,3987319.516910512,18.73152129573292,4.227396168877416,1.7007853166975676e-6,1.2563630984216796e-5,Upregulated
Feature0203,Cystathionine,C7 H14 N2 O4 S,222.06744,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,Cystathionine,7,14,2,4,1,0,0,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,332073.93504513806,5050393.197279649,15.20864080040838,3.926819319736011,4.988391747228443e-4,0.0015097610420815287,Upregulated
Feature0202,methylguanosine,C11 H15 N5 O5,297.10742,NA,NA,methylguanosine,11,15,5,5,0,0,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,9396407.801045677,5346242.301231088,0.5689666109038108,-0.8135841026312006,8.287475833343112e-6,4.36048728462053e-5,Downregulated
Feature0201,melizame,C7 H6 N4 O2,178.04906,NA,NA,melizame,7,6,4,2,0,0,0,0,0.8571428571428571,0.2857142857142857,1.4285714285714284,19.58571428571429,7,5,1,1,1,Lignin,411685.8226220112,384546.8343797625,0.9340783997141279,-0.09838445059272041,0.5208298758226562,0.567273304239963,Downregulated
Feature0200,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11117,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,760268.9574074625,25625069.690861657,33.70526895934806,5.0749022325063855,0.006183125027860551,0.012815931875929143,Upregulated
Feature0199,"1,5-Anhydro-D-glucitol",C6 H12 O5,164.06849,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Fructose and mannose metabolism;Other,Other,"1,5-Anhydro-D-glucitol",6,12,0,5,0,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,915882.1615088957,381076.60219994327,0.4160760174345223,-1.2650809608556142,0.09386230776464187,0.13836598817029103,Downregulated
Feature0198,NA,C7 H6 N4 O5 P2,287.98122,NA,NA,Feature0198,7,6,4,5,0,2,0,0,0.8571428571428571,0.7142857142857143,0.8571428571428572,35.87142857142857,8,3,0.75,0.3333333333333333,-3,Tannin,1689571.765576753,4238623.477819634,2.5086969160926613,1.326938184552469,0.026984319143283156,0.04684587384265401,Upregulated
Feature0197,NA,C18 H28 O15,484.143,NA,NA,Feature0197,18,28,0,15,0,0,0,0,1.5555555555555556,0.8333333333333334,0.11111111111111116,57.133333333333326,5,-10,-3.3333333333333335,-0.23809523809523808,-10,Carbohydrate,6619917.465541152,122445.2736439735,0.018496495504867157,-5.756604237772931,4.122036853465986e-6,2.5631574616097586e-5,Downregulated
Feature0196,NA,C31 H34 O11,582.21017,NA,NA,Feature0196,31,34,0,11,0,0,0,0,1.096774193548387,0.3548387096774194,-0.387096774193548,71.33225806451611,15,4,0.2,0.37254901960784315,4,Lignin,94050.74207397013,85428.56058451606,0.9083241524806599,-0.13872085274450272,0.33031452397441385,0.38925772662004676,Downregulated
Feature0195,NA,C11 H23 N O7,281.14757,NA,NA,Feature0195,11,23,1,7,0,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,4235628.918394361,230120.11620813672,0.05432962156075053,-4.202117191989305,1.2916748436547936e-4,5.136660424766737e-4,Downregulated
Feature0194,Glu-Gly,C7 H12 N2 O5,204.07461,NA,NA,Glu-Gly,7,12,2,5,0,0,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,5136199.710539281,2164416.8145425776,0.42140433326634064,-1.2467229455405957,0.0011554147602449286,0.002993574606089133,Downregulated
Feature0193,NA,C6 H14 O7,198.07397,NA,NA,Feature0193,6,14,0,7,0,0,0,0,2.3333333333333335,1.1666666666666667,0,60.3,0,-7,7,-1.4,-7,Carbohydrate,5446747.724302288,135973712.8393695,24.964202441886975,4.641788910967964,0.011484004517428828,0.022443025971203765,Upregulated
Feature0192,Glycolic acid,C2 H4 O3,76.01606,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Other,Glycolic acid-peak1,2,4,0,3,0,0,0,0,2,1.5,1,31.799999999999997,1,-2,2,-1,-2,Carbohydrate,6864431.300594737,4150700.8349896614,0.6046678381980519,-0.7257852496603177,7.241006430393159e-4,0.002013353007475171,Downregulated
Feature0191,L-glycero-ÃÂ±-D-manno-Heptopyranose,C7 H14 O7,210.07387,Metabolic pathways;Other,NA,L-glycero-ÃÂ±-D-manno-Heptopyranose,7,14,0,7,0,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,1184641.7135598944,1438562.6400822354,1.2143440701233614,0.28017725020245704,0.6404660170772546,0.6866438176815708,Upregulated
Feature0190,NP-001596,C16 H30 O4,286.21438,Metabolic pathways;Other,NA,NP-001596,16,30,0,4,0,0,0,0,1.875,0.25,-1.375,99.4875,2,-2,-0.16666666666666666,0,-2,Lipid,439662.99467508186,526538.5722539253,1.1975958373368354,0.26014111192651784,0.7569969143900575,0.7821539115450141,Upregulated
Feature0189,3-Hydroxybutyric acid,C4 H8 O3,104.04736,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak1,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,1307685.7421905373,1662838.960579596,1.271589118800158,0.3466325762596363,0.28929963117797136,0.3546253543471907,Upregulated
Feature0188,(2S)-5-Carbamimidamido-2-(2-oxo-1-azetidinyl)pentanoic acid,C9 H16 N4 O3,228.12222,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,(2S)-5-Carbamimidamido-2-(2-oxo-1-azetidinyl)pentanoic acid,9,16,4,3,0,0,0,0,1.7777777777777777,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,2481869.4751488008,3889909.679965177,1.5673304816853664,0.6483094133896486,2.9826809665711414e-4,0.0010000753829091475,Upregulated
Feature0187,2'-O-Methylinosine,C11 H14 N4 O5,282.09642,ABC transporters,NA,2'-O-Methylinosine,11,14,4,5,0,0,0,0,1.2727272727272727,0.4545454545454546,0.7272727272727271,39.57272727272728,7,2,-1,0.1111111111111111,-2,Lignin,6567639.576873186,813325.1353576831,0.12383827185366075,-3.0134708507661543,1.5016888416889236e-7,1.9021391994726365e-6,Downregulated
Feature0186,NP-011548,C18 H34 O3,298.25084,Other,NA,NP-011548,18,34,0,3,0,0,0,0,1.8888888888888888,0.16666666666666666,-1.5555555555555554,104.63333333333333,2,-1,-0.06666666666666667,0.0303030303030303,-1,Lipid,338461.12337766506,1606604.4938252782,4.746791825874137,2.2469527806785385,5.416072562989239e-4,0.0015968076004675169,Upregulated
Feature0185,4-Dodecylbenzenesulfonic acid,C18 H30 O3 S,326.19169,NA,NA,4-Dodecylbenzenesulfonic acid,18,30,0,3,1,0,0,0,1.6666666666666667,0.16666666666666666,-1.2222222222222223,95.13333333333333,4,1,0,0.0967741935483871,0,Lipid,2615724.1823252738,7285365.757855653,2.7852194077202954,1.477790981411591,0.46810601563081944,0.5163145307724273,Upregulated
Feature0184,NA,C7 H18 N O7 P,259.0822,NA,NA,Feature0184,7,18,1,7,0,1,0,0,2.5714285714285716,1,-0.8571428571428568,84.72857142857141,0,-7,4.5,-3.6666666666666665,-9,Other,309745.3063078486,2333206.1523732794,7.53266023684104,2.913159457555833,7.220987888689287e-5,2.9753950095563086e-4,Upregulated
Feature0183,Valylvaline,C10 H20 N2 O3,216.1473,NA,NA,Valylvaline,10,20,2,3,0,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,3722527.623584522,2530759.7641773056,0.6798498278812957,-0.5567119904322977,0.06843852088711438,0.10543231596123027,Downregulated
Feature0182,NA,C30 H52 O6 S,540.34851,NA,NA,Feature0182,30,52,0,6,1,0,0,0,1.7333333333333334,0.2,-1.2666666666666666,96.4,5,-1,-0.08695652173913043,0.03846153846153846,-2,Lipid,63165.55863964275,2157302.343942224,34.15314279494552,5.09394643726981,4.7079882630708946e-4,0.0014637563508820416,Upregulated
Feature0181,"Î±,Î±-Trehalose",C12 H22 O11,342.11625,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak3",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,9056310.042443886,854565.940561138,0.09436138300876121,-3.405659626164926,4.377455886072266e-5,1.8950505228312848e-4,Downregulated
Feature0180,Adenosine 5'-monophosphate,C10 H14 N5 O7 P,347.06322,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of plant hormones;Other,Superpathway of anaerobic sucrose degradation;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of purine nucleotide salvage;Superpathway of chorismate metabolism;Other,Adenosine 5'-monophosphate,10,14,5,7,0,1,0,0,1.4,0.7,1,31.799999999999997,7,0,2,-5,-6,Tannin,2852016.33341361,245651.22606262605,0.0861324751841808,-3.5372988992650796,5.610596877033128e-4,0.0016261221457163813,Downregulated
Feature0179,16-Hydroxyhexadecanoic acid,C16 H32 O3,272.23521,Metabolic pathways;Other,NA,16-Hydroxyhexadecanoic acid,16,32,0,3,0,0,0,0,2,0.1875,-1.625,106.6125,1,-2,-0.15384615384615383,-0.03448275862068965,-2,Lipid,985151.2897907385,2540813.343476038,2.579109797456334,1.366873192620701,0.14555704483257473,0.19912203733096223,Upregulated
Feature0178,Sorbic acid,C6 H8 O2,112.05247,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Sorbic acid,6,8,0,2,0,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,615515.9836729156,365132.47993756126,0.5932136445242862,-0.7533763132426023,0.0048267831214229,0.010581793766196359,Downregulated
Feature0177,4-Undecylbenzenesulfonic acid,C17 H28 O3 S,312.17592,NA,NA,4-Undecylbenzenesulfonic acid-peak1,17,28,0,3,1,0,0,0,1.6470588235294117,0.17647058823529413,-1.1764705882352944,93.8294117647059,4,1,0,0.10344827586206896,0,Lipid,2615086.2965876358,2866123.2127854005,1.0959956528108983,0.1322420759621286,0.8420289606673648,0.8570651921078534,Upregulated
Feature0176,4-Carboxy-2-[(5-oxidanidyl-5-oxidanylidenenorvalyl)amino]butanoate,C10 H14 N2 O7,274.08009,NA,NA,4-Carboxy-2-[(5-oxidanidyl-5-oxidanylidenenorvalyl)amino]butanoate,10,14,2,7,0,0,0,0,1.4,0.7,0.6000000000000001,43.2,5,-2,-4,-0.1111111111111111,-4,Tannin,17371522.430159803,9039705.97926969,0.5203749996934801,-0.942376442371669,0.0014413898405582371,0.0036515209294142007,Downregulated
Feature0175,Guanine,C5 H5 N5 O,151.04944,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine,5,5,5,1,0,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,5327469.413106058,224995.81584943994,0.042233150188704945,-4.5654803273828355,1.2671305074914656e-4,5.09833686543625e-4,Downregulated
Feature0174,N-Acetyl-L-methionine,C7 H13 N O3 S,191.0616,NA,NA,N-Acetyl-L-methionine,7,13,1,3,1,0,0,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,832018.0922906125,1837528.5714429722,2.208519969059938,1.1430798770389214,0.07584044170064877,0.11489819948448204,Upregulated
Feature0173,Pyrrole-2-carboxylic acid,C5 H5 N O2,111.03207,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Pyrrole-2-carboxylic acid,5,5,1,2,0,0,0,0,1,0.4,0.3999999999999999,48.9,4,2,0.5,0.6666666666666666,1,Lignin,832791.9934082745,4496219.552915686,5.3989706775572035,2.4326843813625194,0.0024661049338830657,0.005776766351972661,Upregulated
Feature0172,"2,4-Dinitrophenol",C6 H4 N2 O5,184.01199,NA,NA,"2,4-Dinitrophenol",6,4,2,5,0,0,0,0,0.6666666666666666,0.8333333333333334,2,3.299999999999997,6,1,1,1,-1,Condensed HC,365662.68952297914,1272736.484684678,3.4806298841837298,1.7993484119813143,3.0433355580745e-4,0.0010091685631010289,Upregulated
Feature0171,NA,C10 H N2 O4 P,243.96742,NA,NA,Feature0171,10,1,2,4,0,1,0,0,0.1,0.4,0.7999999999999998,37.5,12,8,1.6666666666666667,1.4,5,Other,7643130.622467683,98981.37080138554,0.012950370167745234,-6.2708628539063005,0.3291644802808228,0.38925772662004676,Downregulated
Feature0170,NA,C9 H2 N3 O3 P,230.98339000000001,NA,NA,Feature0170,9,2,3,3,0,1,0,0,0.2222222222222222,0.3333333333333333,0.8888888888888888,34.96666666666667,11,8,2,1.5714285714285714,4,Condensed HC,22798365.740765847,1472530.3978514061,0.06458929620636661,-3.952561089708146,0.3530657245881236,0.4065605313438999,Downregulated
Feature0169,"(2R)-2,3-Dihydroxypropanoic acid",C3 H6 O4,106.02664,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,"(2R)-2,3-Dihydroxypropanoic acid",3,6,0,4,0,0,0,0,2,1.3333333333333333,0.6666666666666665,41.3,1,-3,3,-1,-3,Carbohydrate,3526583.233185182,303869.84663723543,0.08616551107537099,-3.536745663350834,0.010064165068961897,0.02024673207991158,Downregulated
Feature0168,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak1,8,15,1,4,0,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,1818724.3272137986,1096942.665224676,0.6031385014270642,-0.7294387621185922,9.743516834184745e-4,0.0025907511251235388,Downregulated
Feature0167,beta-D-Ethyl glucuronide,C8 H14 O7,222.07389,NA,NA,beta-D-Ethyl glucuronide-peak4,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,16504615.13926009,287304.8561516103,0.0174075465394033,-5.844143309293672,3.098324535836492e-4,0.0010091685631010289,Downregulated
Feature0166,2-Keto-4-methylthiobutyric acid,C5 H8 O3 S,148.01946,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Other,Other,2-Keto-4-methylthiobutyric acid,5,8,0,3,1,0,0,0,1.6,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,398213.75314655073,382668.58874830406,0.9609627636529025,-0.05744756579686588,0.7386340598562761,0.7654934802146861,Downregulated
Feature0165,2-Hydroxycinnamic acid,C9 H8 O3,164.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,2-Hydroxycinnamic acid,9,8,0,3,0,0,0,0,0.8888888888888888,0.3333333333333333,-0.22222222222222232,66.63333333333333,6,3,0.5,0.6,3,Lignin,134077.65944135858,124991.04808257223,0.9322287441722492,-0.10124409752710373,0.7627434934916386,0.7857176951028325,Downregulated
Feature0164,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,1,6,0,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,512341.84479869145,12782069.312920121,24.94832198986681,4.640870878854362,2.778862485377615e-4,9.409613564347964e-4,Upregulated
Feature0163,MFCD00025555,C9 H18 N2 O3,202.13173,NA,NA,MFCD00025555,9,18,2,3,0,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,49821940.52883249,5092329.458859927,0.10221058041512739,-3.2903835490779882,1.4229142145184856e-4,5.529962060969568e-4,Downregulated
Feature0162,NA,C5 H13 O6 P,200.045,NA,NA,Feature0162,5,13,0,6,0,1,0,0,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,3164494.401420833,14999489.35751121,4.739932341411809,2.2448664659998405,0.007087404882722469,0.014514326167012481,Upregulated
Feature0161,NA,C8 H16 O7,224.08956,NA,NA,Feature0161,8,16,0,7,0,0,0,0,2,0.875,-0.25,67.425,1,-6,-6,-0.5555555555555556,-6,Carbohydrate,3660259.6659161327,1554518.603326089,0.4247017275308542,-1.235478117835842,0.31310597608930163,0.3770501543047224,Downregulated
Feature0160,ascopyrone P,C6 H8 O4,144.04231,Microbial metabolism in diverse environments;Other,Other,ascopyrone P,6,8,0,4,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,80496677.79811627,5730624.343800533,0.07119081806298641,-3.8121650102293545,9.00940461115024e-6,4.668509662141487e-5,Downregulated
Feature0159,NA,C8 H11 N O5,201.06374,NA,NA,Feature0159,8,11,1,5,0,0,0,0,1.375,0.625,0.25,53.175,4,-1,-1,0.1111111111111111,-2,Lignin,37033499.24268002,35160475.67361013,0.9494235325483019,-0.07487628582995746,0.6390049457185301,0.6866438176815708,Downregulated
Feature0158,NA,C10 H24 N6 O5 P2,370.12836,NA,NA,Feature0158,10,24,6,5,0,2,0,0,2.4,0.5,-0.5999999999999996,77.39999999999999,3,-2,3.3333333333333335,15,-10,Other,4211881.395183466,3367757.174730169,0.7995849974743822,-0.3226766916797105,0.7730175517562556,0.7939099180199382,Downregulated
Feature0157,3-Hydroxy-3-methylglutaric acid,C6 H10 O5,162.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,3-Hydroxy-3-methylglutaric acid,6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,83363230.61568108,1930473.3793951017,0.023157372442713,-5.432384622929418,7.964381282912442e-7,7.782338282160158e-6,Downregulated
Feature0156,.alpha.-Glucoheptitol,C7 H16 O7,212.08955,NA,NA,.alpha.-Glucoheptitol-peak2,7,16,0,7,0,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,411725.7010685734,14082307.174202226,34.20312877640058,5.096056398470312,0.012182163145041733,0.023538416924317924,Upregulated
Feature0155,NA,C18 H32 O17,520.16402,NA,NA,Feature0155,18,32,0,17,0,0,0,0,1.7777777777777777,0.9444444444444444,0.11111111111111116,57.133333333333326,3,-14,-14,-0.5789473684210527,-14,Carbohydrate,17162970.43389662,497161.19352419284,0.028967083258636082,-5.109441765095565,0.08944511925382335,0.13300100341220691,Downregulated
Feature0154,NA,C12 H23 N O14,405.11204,NA,NA,Feature0154,12,23,1,14,0,0,0,0,1.9166666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-12,4.333333333333333,-1.5,-13,Carbohydrate,749449712.2475115,1931598.2570764213,0.0025773553922434442,-8.599892800132062,9.696863544449718e-6,4.9497422868683636e-5,Downregulated
Feature0153,beta-D-Ethyl glucuronide,C8 H14 O7,222.07391,NA,NA,beta-D-Ethyl glucuronide-peak3,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,43405482.287014954,7938029.544621749,0.1828808050589606,-2.451024435325496,3.8016458699572195e-7,4.063009023516778e-6,Downregulated
Feature0152,4-Acetamidobutanoic acid,C6 H11 N O3,145.07394,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid,6,11,1,3,0,0,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,3290619.3228031835,14375260.557863459,4.368557753929917,2.127157063551412,0.047647540715928395,0.07579283220859306,Upregulated
Feature0151,3-Phenyllactic acid,C9 H10 O3,166.06292,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,3-Phenyllactic acid,9,10,0,3,0,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,6824706.964806694,24583887.60229405,3.602189475543347,1.8488740691501768,0.003728394871868471,0.008334059125353052,Upregulated
Feature0150,Mevalonic acid,C6 H12 O4,148.07362,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Biosynthesis of terpenoids and steroids;Other,Superpathway of branched chain amino acid biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Mevalonic acid-peak1,6,12,0,4,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,251806.7301769942,16690786.226957498,66.28411486549861,6.050591261595467,1.288767395904573e-5,6.296549277133772e-5,Upregulated
Feature0149,N-Acetylvaline,C7 H13 N O3,159.08948,Metabolic pathways;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,1,3,0,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,1727764.807191824,9139211.024226438,5.289615222039745,2.4031627814234553,0.01760314473302696,0.032897680320738906,Upregulated
Feature0148,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05291,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak1",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,1513907.1955046211,814884.3814045051,0.5382657429888791,-0.8936094844895758,1.5821463969285205e-4,6.012156308328378e-4,Downregulated
Feature0147,Acrylic acid,C3 H4 O2,72.02116,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid-peak2,3,4,0,2,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,90286277.48821837,731561.6942319385,0.008102689739616316,-6.947383385324035,1.3679514884020021e-6,1.1139033548416303e-5,Downregulated
Feature0146,"5,7-Dihydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl hydrogen sulfate",C11 H14 O7 S,290.04605,NA,NA,"5,7-Dihydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl hydrogen sulfate",11,14,0,7,1,0,0,0,1.2727272727272727,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Lignin,64771.89020560423,85188.88540019558,1.3152138239255031,0.3952973680646823,0.1486438293351907,0.20161518169562054,Upregulated
Feature0145,DL-4-Hydroxyphenyllactic acid,C9 H10 O4,182.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,DL-4-Hydroxyphenyllactic acid,9,10,0,4,0,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,3262712.951288212,16004978.416154243,4.905420322016076,2.2943767593818882,7.11031616147283e-4,0.002009692667127031,Upregulated
Feature0144,NA,C5 H12 N2 S2,164.04417,NA,NA,Feature0144,5,12,2,0,2,0,0,0,2.4,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Lipid,165741.48830770285,84632.36727888798,0.5106287396295492,-0.9696533559002785,0.009140657098239144,0.01849766111004608,Downregulated
Feature0143,NA,C33 H38 O10,594.2465,NA,NA,Feature0143,33,38,0,10,0,0,0,0,1.1515151515151516,0.30303030303030304,-0.5454545454545459,75.84545454545456,15,5,0.21739130434782608,0.35714285714285715,5,Lignin,73996.49069401677,48589.5163338832,0.6566462257623261,-0.6068117803547116,0.14842019572286305,0.20161518169562054,Downregulated
Feature0142,"2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C21 H24 O8,404.14731,NA,NA,"2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",21,24,0,8,0,0,0,0,1.1428571428571428,0.380952380952381,-0.3809523809523814,71.15714285714287,10,2,0.15384615384615383,0.35294117647058826,2,Lignin,463568.23879366275,243550.45762259967,0.525382106108882,-0.9285610300602685,0.008363143864091089,0.017024971437614,Downregulated
Feature0141,.,C3 H6 O2,74.0368,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Fructose and mannose metabolism;Other,Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Other,.,3,6,0,2,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-1,-1,0,-1,Amino Sugar,6265911.72784518,4897673.48349991,0.7816378040780665,-0.35542784964219876,0.6884859432272872,0.7267351622954699,Downregulated
Feature0140,D-(-)-Glutamine,C5 H10 N2 O3,146.06919,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Central carbon metabolism in cancer;Other,Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of purine nucleotide salvage;Superpathway of chorismate metabolism;Superpathway of butirocin biosynthesis;Other,D-(-)-Glutamine,5,10,2,3,0,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,1538706.5570437848,33146678.594754085,21.54191027718541,4.4290742846591575,4.794027701899941e-4,0.0014770788054502522,Upregulated
Feature0139,"3,12-Dihydroxy-13-methoxypodocarpa-8,11,13-trien-7-one",C18 H24 O4,304.16748,NA,NA,"3,12-Dihydroxy-13-methoxypodocarpa-8,11,13-trien-7-one",18,24,0,4,0,0,0,0,1.3333333333333333,0.2222222222222222,-0.8888888888888893,85.63333333333334,7,3,0.21428571428571427,0.3125,3,Lignin,62151.25377636089,1059307.2543858506,17.044020675714126,4.09119380161776,0.150960581590359,0.20326188544843612,Upregulated
Feature0138,cis-Aconitic acid,C6 H6 O6,174.0164,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Other,Superpathway of betalain biosynthesis;Other,cis-Aconitic acid,6,6,0,6,0,0,0,0,1,1,1,31.799999999999997,4,-2,-Inf,0.3333333333333333,-2,Tannin,5600531.86477261,4710607.781707026,0.8411000768224864,-0.24965062764624424,0.462159625111083,0.5148488331856365,Downregulated
Feature0137,glutaral,C5 H8 O2,100.05245,NA,NA,glutaral,5,8,0,2,0,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,6585856.873735052,176435.7894706735,0.026790103832094226,-5.222156017039482,0.3301372780960601,0.38925772662004676,Downregulated
Feature0136,beta-D-Ethyl glucuronide,C8 H14 O7,222.07396,NA,NA,beta-D-Ethyl glucuronide-peak2,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,71893090.91567935,1792394.6511424214,0.02493138948838147,-5.325892899719664,1.4819683666127332e-5,7.039349741410482e-5,Downregulated
Feature0135,MS 3 (enzyme inhibitor),C21 H24 O7,388.15231,NA,NA,MS 3 (enzyme inhibitor),21,24,0,7,0,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,109629.5640343234,72328.264759055,0.65975145843333,-0.6000054601395972,0.04505889029785252,0.07268934189559227,Downregulated
Feature0134,UDP-N-acetylglucosamine,C17 H27 N3 O17 P2,607.08161,Metabolic pathways;Other,Chitin biosynthesis;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of butirocin biosynthesis;Other,UDP-N-acetylglucosamine,17,27,3,17,0,2,0,0,1.588235294117647,1,0.3529411764705883,50.24117647058823,7,-10,3,-1.8571428571428572,-15,Carbohydrate,2715898.410636566,18259276.70052373,6.723107399383185,2.7491281963223875,8.035175824514526e-6,4.29379708122495e-5,Upregulated
Feature0133,NA,C4 H11 O6 P,186.02928,NA,NA,Feature0133,4,11,0,6,0,1,0,0,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,546350.0225404274,14168149.50791041,25.93236738973875,4.696682012051679,1.8777579851252343e-4,6.831842882051384e-4,Upregulated
Feature0132,(Â±)9-HpODE,C18 H32 O4,312.2302,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,(Â±)9-HpODE,18,32,0,4,0,0,0,0,1.7777777777777777,0.2222222222222222,-1.333333333333333,98.29999999999998,3,-1,-0.07142857142857142,0.0625,-1,Lipid,2226184.2136906856,15879087.968425963,7.132872414947537,2.8344831684346437,2.540351255009216e-4,8.775758880940929e-4,Upregulated
Feature0131,"3,5-Dihydroxybenzoic acid",C7 H6 O4,154.02666,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,"3,5-Dihydroxybenzoic acid",7,6,0,4,0,0,0,0,0.8571428571428571,0.5714285714285714,0.2857142857142856,52.15714285714286,5,1,0.3333333333333333,0.6,1,Lignin,348972.5122124108,1931386.547342915,5.534494780400723,2.468451625755257,0.21411306544582237,0.27842839689152565,Upregulated
Feature0130,Adenosine,C10 H13 N5 O4,267.09685,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine-peak2,10,13,5,4,0,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,49296144.19212447,205209073.5162837,4.162781428026328,2.0575478099840607,4.740730908209417e-6,2.8671511358608825e-5,Upregulated
Feature0129,1-Deoxy-L-mannitol,C6 H14 O5,166.08408,NA,NA,1-Deoxy-L-mannitol-peak2,6,14,0,5,0,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,953802.2449160544,176303280.8001345,184.84259367165907,7.530153428121454,8.76786017883839e-7,8.109386735464687e-6,Upregulated
Feature0128,Methyl acetoacetate,C5 H8 O3,116.04739,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-lysine degradation;Other,Methyl acetoacetate,5,8,0,3,0,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,6920378.423812771,114204921.33775096,16.502698890681465,4.044630080436887,0.003168180746810934,0.00715387311373377,Upregulated
Feature0127,4-Hydroxy-2-methylbenzoic acid,C8 H8 O3,152.04741,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,4-Hydroxy-2-methylbenzoic acid,8,8,0,3,0,0,0,0,1,0.375,-0.25,67.425,5,2,0.4,0.5384615384615384,2,Lignin,91797846.59514777,56477097.12515463,0.61523335481096,-0.7007943739089727,0.7042872624742651,0.738853508485272,Downregulated
Feature0126,4-Nitrophenol,C6 H5 N O3,139.02701,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,4-Nitrophenol,6,5,1,3,0,0,0,0,0.8333333333333334,0.5,0.6666666666666665,41.3,5,2,0.5,0.7142857142857143,1,Lignin,3700369.115260135,74851543.50879952,20.22812891830589,4.338290973106679,0.2998965649455225,0.3649986662326289,Upregulated
Feature0125,D-(â)-Erythrose,C4 H8 O4,120.04229,NA,NA,D-(â)-Erythrose-peak2,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,153562914.99832386,9318671.562230341,0.060683085902166256,-4.04256173730528,9.751059791569444e-8,1.3339449794866999e-6,Downregulated
Feature0124,Acrylic acid,C3 H4 O2,72.02115,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid-peak1,3,4,0,2,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,318162372.24423915,22122747.416605853,0.06953288429601977,-3.8461607545197363,1.7547729220798718e-6,1.2563630984216796e-5,Downregulated
Feature0123,"1,5-Anhydro-D-fructose",C6 H10 O5,162.0528,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,"1,5-Anhydro-D-fructose",6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,258713044.6881686,16765301.691103712,0.06480269176728691,-3.947802448907713,8.876242077701628e-7,8.109386735464687e-6,Downregulated
Feature0122,NA,C7 H8 O6 S,220.00407,NA,NA,Feature0122,7,8,0,6,1,0,0,0,1.1428571428571428,0.8571428571428571,0.8571428571428572,35.87142857142857,4,-2,-Inf,0,-3,Tannin,209894.2071451141,137685.10339627956,0.6559738130413886,-0.6082898723449383,0.34024271031851483,0.39714336835812997,Downregulated
Feature0121,Xylitol,C5 H12 O5,152.0685,Metabolic pathways;ABC transporters;Other,Other,Xylitol,5,12,0,5,0,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,13306027.788933227,296293338.10421723,22.26760253354106,4.476874331990936,0.010517841136758351,0.020913381795182304,Upregulated
Feature0120,Gluconic acid,C6 H12 O7,196.05834,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,Gluconic acid,6,12,0,7,0,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,116251909.0994396,950436.0507060084,0.008175659720934338,-6.934449133535363,0.0882576448464649,0.13180836042572486,Downregulated
Feature0119,NA,C27 H37 N O5,455.26725,NA,NA,Feature0119,27,37,1,5,0,0,0,0,1.3703703703703705,0.18518518518518515,-0.8888888888888893,85.63333333333334,10,5,0.1904761904761905,0.2765957446808511,4,Lignin,77482.84401021212,308076851.6825046,3976.065355085579,11.957125755516751,0.005773022479403003,0.012263190608421284,Upregulated
Feature0118,Glyceraldehyde,C3 H6 O3,90.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Galactose metabolism;Carbon metabolism;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Other,Superpathway of anaerobic sucrose degradation;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Superpathway of coenzyme A biosynthesis II (plants);Other,Glyceraldehyde,3,6,0,3,0,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,2769661977.379991,172903506.58905724,0.062427656515911104,-4.001670880577012,1.2452233768699963e-6,1.0386985241208262e-5,Downregulated
Feature0117,D-(+)-Glucose,C6 H12 O6,180.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of scopolin and esculin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of betalain biosynthesis;Other,D-(+)-Glucose,6,12,0,6,0,0,0,0,2,1,0,60.3,1,-5,-Inf,-0.6666666666666666,-5,Carbohydrate,5543549403.580542,371401875.8766331,0.06699712563880951,-3.8997569884668386,1.2238280679491366e-9,1.4640186925060366e-7,Downregulated
Feature0116,L-Iditol,C6 H14 O6,182.07904,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak3,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,182458670.40450665,1163144680.7014492,6.374839179320907,2.672388946971849,0.0013168309872720833,0.0033608671466197945,Upregulated
Feature0115,D-(+)-Maltose,C12 H22 O11,342.11635,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,D-(+)-Maltose,12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,5967173005.81427,8625133.14674719,0.0014454303802391966,-9.434285162185754,2.140378205418182e-9,1.4640186925060366e-7,Downregulated
Feature0114,NA,C29 H30 O10,538.1839,NA,NA,Feature0114,29,30,0,10,0,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,358101.74061188655,147321.8747791172,0.41139670119276467,-1.2813978693082297,0.10488480223312431,0.152640861122249,Downregulated
Feature0113,NA,C29 H30 O10,538.18389,NA,NA,Feature0113,29,30,0,10,0,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,356732.945468375,147674.09320467155,0.4139625876460102,-1.2724277065263012,0.10603215023680519,0.15284800503821683,Downregulated
Feature0112,MFCD12974029,C4 H11 N O4 S,169.04083,NA,NA,MFCD12974029,4,11,1,4,1,0,0,0,2.75,1,0.5,46.05,0,-4,3,-Inf,-6,Other,23682173.456774168,202163683.12626675,8.536534178134685,3.093650456391163,4.2239973896300306e-7,4.377597294707486e-6,Upregulated
Feature0111,Perillic acid,C10 H14 O2,166.09931,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Perillic acid,10,14,0,2,0,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,648170.2588755107,164395.70946425255,0.2536304423307809,-1.9792001776283894,0.08076826934785485,0.12168611505271522,Downregulated
Feature0110,NA,C12 H23 N O14,405.11202,NA,NA,Feature0110,12,23,1,14,0,0,0,0,1.9166666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-12,4.333333333333333,-1.5,-13,Carbohydrate,631538715.5269234,1450685.346142445,0.002297064788707479,-8.765992736161833,1.943734859158438e-5,8.983207051786296e-5,Downregulated
Feature0109,MFCD00155202,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,MFCD00155202-peak1,10,12,0,4,0,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,5716308.942924225,2332084.6783373365,0.40797037067495157,-1.2934637162997011,0.45521447255032266,0.5087691163797724,Downregulated
Feature0108,3-Allyl-2-hydroxybenzoic acid,C10 H10 O3,178.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,NA,3-Allyl-2-hydroxybenzoic acid-peak2,10,10,0,3,0,0,0,0,1,0.3,-0.4000000000000003,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Lignin,6067569.716027085,636346.986661113,0.10487674908460375,-3.2532332234390284,0.31983327477566903,0.38379992973080285,Downregulated
Feature0107,beta-D-Ethyl glucuronide,C8 H14 O7,222.0739,NA,NA,beta-D-Ethyl glucuronide-peak1,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,915971777.6971517,798221.0925128215,8.71447256289525e-4,-10.164299030622738,8.186812085801415e-9,2.6275521232206993e-7,Downregulated
Feature0106,DL-Lactic Acid,C3 H6 O3,90.03169,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Galactose metabolism;Carbon metabolism;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Other,Superpathway of anaerobic sucrose degradation;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Superpathway of coenzyme A biosynthesis II (plants);Other,DL-Lactic Acid,3,6,0,3,0,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,768015797.8545129,7494758.695859301,0.009758599649637743,-6.67911014747539,1.4208370344882132e-6,1.1300610832441137e-5,Downregulated
Feature0105,Gentisyl Alcohol,C7 H8 O3,140.04739,Microbial metabolism in diverse environments;Other,NA,Gentisyl Alcohol,7,8,0,3,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,16384751.114348842,10665615.740738472,0.6509476809445172,-0.6193865015350506,0.6201379327824128,0.6690447098157261,Downregulated
Feature0104,NA,C10 H5 N2 O6 P,279.98865,NA,NA,Feature0104,10,5,2,6,0,1,0,0,0.5,0.6,0.7999999999999998,37.5,10,4,1,1,1,Condensed HC,1627195658.190317,114168434.06609453,0.0701626958574034,-3.8331520083349138,2.2142253127184562e-7,2.7045180605346857e-6,Downregulated
Feature0103,NA,C28 H28 O10,524.16829,NA,NA,Feature0103,28,28,0,10,0,0,0,0,1,0.35714285714285715,-0.2857142857142856,68.44285714285714,15,5,0.2777777777777778,0.43478260869565216,5,Lignin,188219.05891884753,138641.57892447844,0.7365969191475721,-0.44105273177924526,0.031388265363735846,0.053142508685136924,Downregulated
Feature0102,NA,C10 H3 N2 O5 P,261.97802,NA,NA,Feature0102,10,3,2,5,0,1,0,0,0.3,0.5,0.7999999999999998,37.5,11,6,1.5,1.2222222222222223,3,Condensed HC,16122008.281328212,67966533.72448176,4.215760998162838,2.075793079370995,4.8624200549687485e-6,2.8671511358608825e-5,Upregulated
Feature0101,Phenylacetaldehyde,C8 H8 O,120.05755,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,Phenylacetaldehyde,8,8,0,1,0,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,240232.9384616046,93572.54098443793,0.3895075404049692,-1.3602768374616316,0.002581614390269686,0.00600620490797437,Downregulated
Feature0100,Î´-Gluconic acid Î´-lactone,C6 H10 O6,178.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,Î´-Gluconic acid Î´-lactone,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,9080535.882747158,825037.1733369622,0.09085776258034692,-3.4602464110582782,0.07592688036109048,0.11489819948448204,Downregulated
Feature0099,NA,C18 H34 O18,538.17464,NA,NA,Feature0099,18,34,0,18,0,0,0,0,1.8888888888888888,1,0.11111111111111116,57.133333333333326,2,-16,-Inf,-0.7777777777777778,-16,Carbohydrate,9638796.238911718,261200.01033402875,0.02709882062653914,-5.20562612466303,0.045668150802096276,0.07332632663998558,Downregulated
Feature0098,"8-(3-Furyl)-10-methyl-6,15-dioxo-7,14-dioxatetracyclo[11.2.1.0~2,11~.0~5,10~]hexadec-3-yl acetate",C21 H24 O7,388.15237,NA,NA,"8-(3-Furyl)-10-methyl-6,15-dioxo-7,14-dioxatetracyclo[11.2.1.0~2,11~.0~5,10~]hexadec-3-yl acetate",21,24,0,7,0,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,95604.66808598035,69692.252631325,0.7289628637029367,-0.4560827751448678,0.041003638447791015,0.0677451417833069,Downregulated
Feature0097,NA,C32 H36 O11,596.22573,NA,NA,Feature0097,32,36,0,11,0,0,0,0,1.125,0.34375,-0.4375,72.76875,15,4,0.1904761904761905,0.3584905660377358,4,Lignin,137961.9952394178,71889.8263629424,0.5210842756962565,-0.9404113744055748,0.06995983559728826,0.10729266266489948,Downregulated
Feature0096,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,0,6,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,13777595.285321446,114014.45176716412,0.008275352077487304,-6.916963591516909,0.33394510067014116,0.39112748092187766,Downregulated
Feature0095,1-Deoxy-L-mannitol,C6 H14 O5,166.08409,NA,NA,1-Deoxy-L-mannitol-peak1,6,14,0,5,0,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,1218867.1538214236,28913616.265480414,23.72171255483397,4.568136261819339,1.4342331623578618e-5,6.908559739808291e-5,Upregulated
Feature0094,NA,C9 H17 N O6,235.10561,NA,NA,Feature0094,9,17,1,6,0,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,1633471.1652991723,47871925.18045309,29.306868830883396,4.873166932465644,0.006693065748614582,0.013789328229073416,Upregulated
Feature0093,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00412,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak1,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,150631.87291443528,100020.4304344519,0.6640057545541332,-0.5907323502568251,0.0420769403657272,0.06885317514391724,Downregulated
Feature0092,L-Saccharopine,C11 H20 N2 O6,276.13221,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,2,6,0,0,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,1389959.3516549363,21089032.901191633,15.1724098090223,3.923378339563835,1.6415833709454617e-4,6.169467174322505e-4,Upregulated
Feature0091,L-Iditol,C6 H14 O6,182.07903,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak2,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,918741.4981183561,27787408.62019567,30.24507837852773,4.918628494247653,3.1737295839370347e-5,1.40963054247593e-4,Upregulated
Feature0090,EPERVUDINE,C12 H18 N2 O5,270.12157,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,EPERVUDINE,12,18,2,5,0,0,0,0,1.5,0.4166666666666667,-0.16666666666666696,65.05000000000001,5,0,-0.4,0.06666666666666667,-2,Protein,13032355.423608368,144187.70078636982,0.01106382507993689,-6.498005937130881,0.28563395026753624,0.3513914064442352,Downregulated
Feature0089,"2,4,6-Trihydroxyacetophenone",C8 H8 O4,168.04223,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"2,4,6-Trihydroxyacetophenone-peak1",8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,434434.1716181014,249344.48580304373,0.5739522857383219,-0.8009972882824533,0.0012206224568488146,0.0031387434604683807,Downregulated
Feature0088,N-Acetyl-b-D-galactosamine,C8 H15 N O6,221.08996,Metabolic pathways;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of CMP-sialic acids biosynthesis;Other,N-Acetyl-b-D-galactosamine,8,15,1,6,0,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,4251949.0883132,57694363.6296313,13.568921553696065,3.762234156030092,0.0029058648678134493,0.006625371898614664,Upregulated
Feature0087,NA,C15 H31 O17 P,514.12992,NA,NA,Feature0087,15,31,0,17,0,1,0,0,2.066666666666667,1.1333333333333333,-0.13333333333333375,64.10000000000001,1,-16,5.666666666666667,-1.5454545454545454,-17,Carbohydrate,1150381.6515896467,9140893.11554424,7.945965674011719,2.990222561102826,0.06841934674826837,0.10543231596123027,Upregulated
Feature0086,3-Allyl-2-hydroxybenzoic acid,C10 H10 O3,178.06298,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,NA,3-Allyl-2-hydroxybenzoic acid-peak1,10,10,0,3,0,0,0,0,1,0.3,-0.4000000000000003,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Lignin,5426772.284212241,71438.0098975508,0.013163996231310609,-6.247258671225522,0.3299297986880032,0.38925772662004676,Downregulated
Feature0085,NA,C6 H13 N O9,243.05903,NA,NA,Feature0085,6,13,1,9,0,0,0,0,2.1666666666666665,1.5,1.3333333333333337,22.29999999999999,1,-8,2.25,-9,-9,Carbohydrate,233379152.514316,19449174.78372312,0.08333724145531836,-3.5848948435691343,4.225420009491797e-9,2.00941174471851e-7,Downregulated
Feature0084,6-Deoxy-3-O-methyl-beta-D-galactopyranose,C7 H14 O5,178.08412,NA,NA,6-Deoxy-3-O-methyl-beta-D-galactopyranose-peak1,7,14,0,5,0,0,0,0,2,0.7142857142857143,-0.5714285714285712,76.58571428571427,1,-4,-2,-0.3333333333333333,-4,Carbohydrate,609193660.0810965,2857208.0904985457,0.004690147448544017,-7.736151005857594,3.16515153693452e-4,0.0010212092694637791,Downregulated
Feature0083,D-Raffinose,C18 H32 O16,504.16918,Metabolic pathways;ABC transporters;Galactose metabolism;Other,NA,D-Raffinose,18,32,0,16,0,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,18875333.727516666,2351888.5932112606,0.12460116611250438,-3.004610524624526,0.10535378442325058,0.15267370454555804,Downregulated
Feature0082,"7a-Hydroxy-3,6-dimethyl-5,6,7,7a-tetrahydro-1-benzofuran-2(4H)-one",C10 H14 O3,182.09428,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"7a-Hydroxy-3,6-dimethyl-5,6,7,7a-tetrahydro-1-benzofuran-2(4H)-one",10,14,0,3,0,0,0,0,1.4,0.3,-0.7999999999999998,83.1,4,1,0.14285714285714285,0.29411764705882354,1,Lignin,143482.14436426086,11770978.331173312,82.03793150240426,6.358219211170693,1.655879705301987e-5,7.757683002921638e-5,Upregulated
Feature0081,9(S)-HpOTrE,C18 H30 O4,310.2145,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,9(S)-HpOTrE,18,30,0,4,0,0,0,0,1.6666666666666667,0.2222222222222222,-1.2222222222222223,95.13333333333333,4,0,0,0.125,0,Lipid,745693.4108996242,34750498.96937197,46.601590494742396,5.54230728924589,0.0031794991616594533,0.00715387311373377,Upregulated
Feature0080,"4-(1,3-Benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C22 H26 O7,402.16802,NA,NA,"4-(1,3-Benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",22,26,0,7,0,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,201186.40142674284,112523.64437024696,0.5593004476061456,-0.8383046099797309,0.1387696798061128,0.19147795433283868,Downregulated
Feature0079,Glycerol 3-phosphate,C3 H9 O6 P,172.01364,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Other,Glycerol 3-phosphate,3,9,0,6,0,1,0,0,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,7775387.686488601,45261177.48818874,5.821083052468203,2.5412876014252457,3.6328443081800075e-4,0.0011504006975903357,Upregulated
Feature0078,Glucose 1-phosphate,C6 H13 O9 P,260.02973,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of butirocin biosynthesis;Other,Glucose 1-phosphate,6,13,0,9,0,1,0,0,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,2253776.091224337,1761202.538678028,0.7814452134512065,-0.3557833644044764,0.46884232269635584,0.5163145307724273,Downregulated
Feature0077,NA,C6 H7 N3 O6 P2,278.98094,NA,NA,Feature0077,6,7,3,6,0,2,0,0,1.1666666666666667,1,0.6666666666666665,41.3,6,0,1,1,-5,Tannin,2021939.4971261069,431610.9231212188,0.21346381715906484,-2.227936546020703,0.03551214012499546,0.059244643525602186,Downregulated
Feature0076,Azelaic acid,C9 H16 O4,188.10484,NA,NA,Azelaic acid,9,16,0,4,0,0,0,0,1.7777777777777777,0.4444444444444444,-0.8888888888888893,85.63333333333334,2,-2,-0.4,0,-2,Protein,12805642.081231793,11074618.194648309,0.8648233430543473,-0.20952263049398118,0.46951409084861084,0.5163145307724273,Downregulated
Feature0075,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15171,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,6,12,2,0,0,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,194673.55254774573,158699.45091132788,0.8152080692748707,-0.2947597629061785,0.13870243786039718,0.19147795433283868,Downregulated
Feature0074,NA,C18 H22 O7 S,382.10881,NA,NA,Feature0074,18,22,0,7,1,0,0,0,1.2222222222222223,0.3888888888888889,-0.33333333333333304,69.79999999999998,8,1,0,0.25925925925925924,0,Lignin,75015.38726970227,386202.5973490762,5.148311718508695,2.364099408090816,0.02555644246189061,0.044593384295747905,Upregulated
Feature0073,N-Phenylacetylglutamic acid,C13 H15 N O5,265.0951,NA,NA,N-Phenylacetylglutamic acid,13,15,1,5,0,0,0,0,1.1538461538461535,0.38461538461538464,-0.1538461538461542,64.6846153846154,7,2,0.14285714285714285,0.3684210526315789,1,Lignin,1223988.3630452824,1461599.6111478168,1.1941286823277941,0.25595831344758996,0.20753681784838576,0.2709068385654501,Upregulated
Feature0072,Pyruvic acid,C3 H4 O3,88.01606,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Carbon metabolism;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,Pyruvic acid,3,4,0,3,0,0,0,0,1.3333333333333333,1,0.6666666666666665,41.3,2,-1,-Inf,0.3333333333333333,-1,Tannin,4282368.677793264,4715967.435518445,1.1012520850840468,0.13914475071215104,0.7314960312801856,0.7604001297806184,Upregulated
Feature0071,Phenylpyruvic acid,C9 H8 O3,164.04728,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Phenylpyruvic acid,9,8,0,3,0,0,0,0,0.8888888888888888,0.3333333333333333,-0.22222222222222232,66.63333333333333,6,3,0.5,0.6,3,Lignin,2175924.9428231553,2859045.399827211,1.313944862508787,0.3939047366540507,0.724599700731211,0.7555277367380311,Upregulated
Feature0070,2-isopropylmaleic acid,C7 H10 O4,158.05784,Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,2-isopropylmaleic acid,7,10,0,4,0,0,0,0,1.4285714285714286,0.5714285714285714,-0.2857142857142856,68.44285714285714,3,-1,-0.3333333333333333,0.2,-1,Lignin,1530056.0995072008,8269166.778479749,5.404486006194855,2.43415741692856,5.130736037590946e-9,2.00941174471851e-7,Upregulated
Feature0069,L-Serine,C3 H7 N O3,105.04262,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Carbon metabolism;Biosynthesis of amino acids;Central carbon metabolism in cancer;Other,Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of chorismate metabolism;Other,L-Serine,3,7,1,3,0,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,11208096.553874558,9091380.688379396,0.8111440372305296,-0.30196997409819465,0.23468034789133488,0.2994801454434199,Downregulated
Feature0068,NA,C8 H21 N8 O8 P,388.12197,NA,NA,Feature0068,8,21,8,8,0,1,0,0,2.625,1,1.75,10.424999999999995,3,-5,1.5555555555555556,2,-14,Other,381216208.2256258,174617337.3164232,0.4580532872124749,-1.126412652186786,5.517366234029063e-4,0.0016127685914854183,Downregulated
Feature0067,Propylparaben,C10 H12 O3,180.07863,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,NA,Propylparaben,10,12,0,3,0,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,159273.6287404284,15526578.858219067,97.48367624324716,6.607088752984887,1.0345485123163029e-5,5.203170459002582e-5,Upregulated
Feature0066,NA,C19 H32 O3 S,340.20729,NA,NA,Feature0066,19,32,0,3,1,0,0,0,1.6842105263157894,0.15789473684210523,-1.2631578947368425,96.3,4,1,0,0.09090909090909093,0,Lipid,4312501.879882658,5648366.914287884,1.3097656700480267,0.38930872252641685,0.6910831561802357,0.7272321212727404,Upregulated
Feature0065,3-Hydroxyvaleric acid,C5 H10 O3,118.06304,Metabolic pathways;Other,NA,3-Hydroxyvaleric acid,5,10,0,3,0,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,1928387.431460623,1699755.1778904062,0.881438631138016,-0.18206796735539502,0.8354451962650679,0.8529022600676216,Downregulated
Feature0064,D-Glucopyranuronic acid,C6 H10 O7,194.04263,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucopyranuronic acid,6,10,0,7,0,0,0,0,1.6666666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-5,5,-0.6,-5,Carbohydrate,4468989.261976411,5240076.421783615,1.1725417347425424,0.22963927407074805,0.6764496823363426,0.7184651905559911,Upregulated
Feature0063,APM,C7 H13 N O4,175.08439,NA,NA,APM,7,13,1,4,0,0,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,1408133.3500094402,270364.0913835129,0.19200176700715196,-2.380808506645489,0.044883934653023205,0.07268934189559227,Downregulated
Feature0062,D-Glucono-delta-lactone,C6 H10 O6,178.04772,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucono-delta-lactone-peak1,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,4320124.25114874,7073205.670365454,1.6372690365293678,0.7112914053646274,0.03230688124383795,0.05442834179996345,Upregulated
Feature0061,NA,C3 H9 N7 O11,319.03608,NA,NA,Feature0061,3,9,7,11,0,0,0,0,3,3.6666666666666665,11.333333333333332,-262.69999999999993,3,-8,1,1,-15,Other,1201795.7228041359,4544328.779725022,3.7812822042017196,1.9188755243871283,0.015114481150800633,0.02840193710754844,Upregulated
Feature0060,NA,C9 H18 O10,286.09013,NA,NA,Feature0060,9,18,0,10,0,0,0,0,2,1.1111111111111112,0.22222222222222232,53.96666666666666,1,-9,9,-1,-9,Carbohydrate,1800156.9591533563,204543.20684510784,0.11362520684935602,-3.137645174106981,0.02260178987847967,0.04047022062010496,Downregulated
Feature0059,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03784,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,3367593.6291567264,736677.9404661652,0.21875499884783767,-2.19261211003115,0.2747149026276751,0.3416454425405996,Downregulated
Feature0058,NA,C11 H16 N2 O7,288.09583,NA,NA,Feature0058,11,16,2,7,0,0,0,0,1.4545454545454546,0.6363636363636364,0.36363636363636376,49.93636363636363,5,-2,-2,-0.09090909090909093,-4,Lignin,70679863.65355179,14171585.194589622,0.20050385586556624,-2.318298113645365,2.5359542031881056e-6,1.7345926749806644e-5,Downregulated
Feature0057,NA,C17 H32 O17,508.16405,NA,NA,Feature0057,17,32,0,17,0,0,0,0,1.8823529411764703,1,0.11764705882352944,56.94705882352941,2,-15,-Inf,-0.7647058823529411,-15,Carbohydrate,22597511.839290623,122742.8021239353,0.005431695444917108,-7.524381694701231,5.705994459438504e-4,0.0016398740379226626,Downregulated
Feature0056,NA,C7 H16 N O7 P,257.0665,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0056,7,16,1,7,0,1,0,0,2.2857142857142856,1,-0.5714285714285712,76.58571428571427,1,-6,4,-3,-8,Carbohydrate,477179.13542086823,3128908.883072848,6.557094916384337,2.71305677855965,0.010311353551440377,0.020622707102880753,Upregulated
Feature0055,"5,7-Dihydroxy-4-methylcoumarin",C10 H8 O4,192.04227,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,"5,7-Dihydroxy-4-methylcoumarin",10,8,0,4,0,0,0,0,0.8,0.4,0,60.3,7,3,0.5,0.625,3,Condensed HC,2121732.4682151447,231662.33678409617,0.10918546058682715,-3.1951473387745106,0.36745430961418046,0.42029890932458097,Downregulated
Feature0054,Dichloroacetic acid,C2 H2 Cl2 O2,127.94324,Microbial metabolism in diverse environments;Other,NA,Dichloroacetic acid,3,2,0,2,0,0,0,2,0.6666666666666666,0.6666666666666666,0.6666666666666665,41.3,3,1,1,1,1,Condensed HC,3434762.6049360186,2041397.1834191023,0.5943342868835992,-0.7506534830956522,0.028693559607642125,0.049312549677455304,Downregulated
Feature0053,Uridine 5'-diphosphogalactose,C15 H24 N2 O17 P2,566.05509,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of anaerobic sucrose degradation;Superpathway of scopolin and esculin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of betalain biosynthesis;Other,Uridine 5'-diphosphogalactose,15,24,2,17,0,2,0,0,1.6,1.1333333333333333,0.3999999999999999,48.9,6,-11,2.5,-2.6,-15,Carbohydrate,1398377.4863663865,4217491.684797789,3.0159894062344557,1.5926313610999934,1.448591676018704e-4,5.566498350543784e-4,Upregulated
Feature0052,N-Acetylglucosaminitol,C8 H17 N O6,223.10559,NA,NA,N-Acetylglucosaminitol-peak1,8,17,1,6,0,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,213272.73719237835,953442.5963076929,4.470531999819833,2.1604465244359763,0.004916758591858245,0.010642604040604556,Upregulated
Feature0051,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08486,NA,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,1250720.982889551,498184.1223782246,0.39831755378986744,-1.328009034448248,0.23013913450761844,0.29575747801861896,Downregulated
Feature0050,NA,C8 H7 N3 O6 P2,302.98095,NA,NA,Feature0050,8,7,3,6,0,2,0,0,0.875,0.75,0.5,46.05,8,2,1,NA,-3,Tannin,20769147.157055758,2603096.498964965,0.1253347804452641,-2.996141276292146,1.2242723215827186e-6,1.0386985241208262e-5,Downregulated
Feature0049,NA,C7 H12 O8,224.05313,NA,NA,Feature0049,7,12,0,8,0,0,0,0,1.7142857142857142,1.1428571428571428,0.5714285714285716,44.014285714285705,2,-6,6,-0.6666666666666666,-6,Carbohydrate,1319449.2564855246,214120.38256972286,0.16228011916127213,-2.623441827868244,0.13633884618746114,0.19031789957596618,Downregulated
Feature0048,Adenosine,C10 H13 N5 O4,267.09688,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine-peak1,10,13,5,4,0,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,1482525.0012940138,6770820.962154947,4.567087203416518,2.1912743366257197,7.206675608170119e-4,0.002013353007475171,Upregulated
Feature0047,3797,C8 H10 O4,170.05789,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,3797,8,10,0,4,0,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,552723.551462966,459275.1254861671,0.8309309857894481,-0.2671994381011527,0.2462765036173204,0.31310990422722523,Downregulated
Feature0046,Threonine,C4 H9 N O3,119.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Threonine,4,9,1,3,0,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,10164207.93209318,8823364.718668101,0.8680818788455313,-0.20409696853868825,0.3009673901386586,0.36500300506177746,Downregulated
Feature0045,NA,C11 H25 N O7,283.16316,NA,NA,Feature0045,11,25,1,7,0,0,0,0,2.272727272727273,0.6363636363636364,-0.7272727272727275,81.02727272727273,0,-7,-2.6666666666666665,-0.6923076923076923,-8,Other,7559328.790055673,240470.14671981367,0.031811044789605274,-4.974328433803327,0.0018862301146818292,0.004542892248036518,Downregulated
Feature0044,NA,C8 H9 N3 O5 P2,289.00169,NA,NA,Feature0044,8,9,3,5,0,2,0,0,1.125,0.625,0,60.3,7,2,1.5,-1,-3,Lignin,840422.0745760544,5758400.569868271,6.851795953566618,2.7764821886138593,0.04424067418297077,0.07204909795512383,Upregulated
Feature0043,NA,C7 H7 N3 O6 P2,290.98097,NA,NA,Feature0043,7,7,3,6,0,2,0,0,1,0.8571428571428571,0.5714285714285716,44.014285714285705,7,1,1,1,-4,Tannin,3095630.309559786,264266.88734383555,0.08536771543027552,-3.550165618696994,0.020960432803091587,0.03815257567254487,Downregulated
Feature0042,NA,C19 H30 O16,514.15333,NA,NA,Feature0042,19,30,0,16,0,0,0,0,1.5789473684210529,0.8421052631578947,0.10526315789473673,57.3,5,-11,-3.6666666666666665,-0.2727272727272727,-11,Carbohydrate,31451192.9799255,179433.46343472175,0.005705140137267594,-7.453521960311508,7.529574188472193e-8,1.1705065329352227e-6,Downregulated
Feature0041,NA,C16 H39 N7 O11 P2,567.2184,NA,NA,Feature0041,16,39,7,11,0,2,0,0,2.4375,0.6875,-0.375,70.9875,2,-9,4.5,-8.333333333333334,-18,Other,1776645.6693805202,1027021.4493072325,0.5780676850805787,-0.7906896692667952,0.3848266434843933,0.43435878571505776,Downregulated
Feature0040,"Î±,Î±-Trehalose",C12 H22 O11,342.11632,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak2",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,1338962666.715411,671244.663502345,5.013169374983136e-4,-10.961989401698839,4.4299662202197436e-8,8.755764849732977e-7,Downregulated
Feature0039,NA,C13 H16 N7 O5 P S2,445.03926,NA,NA,Feature0039,13,16,7,5,2,1,0,0,1.2307692307692308,0.38461538461538464,1.076923076923077,29.6076923076923,10,5,2.5,-5,-5,Lignin,57836526.840023056,535796.7211805952,0.009263985070587299,-6.7541513563141065,1.7431020338557635e-6,1.2563630984216796e-5,Downregulated
Feature0038,(6-Hydroxy-1-oxo-1H-isochromen-3-yl)methyl hydrogen sulfate,C10 H8 O7 S,271.99907,Other,NA,(6-Hydroxy-1-oxo-1H-isochromen-3-yl)methyl hydrogen sulfate,10,8,0,7,1,0,0,0,0.8,0.7,0.7999999999999998,37.5,7,0,-0.5,0.4545454545454546,-1,Condensed HC,4631551.920944749,478979.1839603019,0.10341656363480843,-3.2734608225804447,0.36550465386718756,0.419471783968383,Downregulated
Feature0037,NA,C16 H26 N2 O10,406.15889,NA,NA,Feature0037,16,26,2,10,0,0,0,0,1.625,0.625,0,60.3,5,-5,-1.75,-0.2222222222222222,-7,Amino Sugar,4474546.521335568,689196.9904509352,0.15402610905143138,-2.698753171198802,6.768946774286901e-5,2.823146093666e-4,Downregulated
Feature0036,Linoleic acid,C18 H32 O2,280.24026,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,Linoleic acid,18,32,0,2,0,0,0,0,1.7777777777777777,0.1111111111111111,-1.5555555555555554,104.63333333333333,3,1,0.0625,0.1176470588235294,1,Lipid,279249.5094709217,9760220.057299701,34.951610392411574,5.127287024068108,1.6685524368657346e-4,6.202662319653056e-4,Upregulated
Feature0035,trimetaphosphoric acid,H3 O9 P3,239.89901,NA,NA,trimetaphosphoric acid,0,3,0,9,0,3,0,0,Inf,Inf,NA,NA,1,-8,0.9166666666666666,0.8666666666666667,-11,Other,17981244.066077095,24351242.177598186,1.3542579194249718,0.4375025274209109,0.0572625390944141,0.09066568689948899,Upregulated
Feature0034,Monomethyl phthalate,C9 H8 O4,180.04223,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Monomethyl phthalate,9,8,0,4,0,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,909777.2859184707,8905127.57875964,9.788250065805302,3.2910509592114168,0.005147929059017038,0.01100369836364892,Upregulated
Feature0033,NA,C10 H6 S,158.01901,NA,NA,Feature0033,10,6,0,0,1,0,0,0,0.6,0,-0.4000000000000003,71.7,8,8,0.7777777777777778,0.7777777777777778,7,Condensed HC,54961664.29721061,7118269.294682807,0.12951335054539223,-2.9488272728606795,1.10647446523663e-7,1.4554394888881824e-6,Downregulated
Feature0032,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid,C9 H12 O5,200.06847,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid-peak1,9,12,0,5,0,0,0,0,1.3333333333333333,0.5555555555555556,-0.22222222222222232,66.63333333333333,4,-1,-0.25,0.2307692307692308,-1,Lignin,6390271.857713656,2798254.8150553186,0.4378929218289146,-1.1913499648612522,0.0021674174389348876,0.0051121156145912516,Downregulated
Feature0031,1-(beta-D-ribofuranosyl)thymine,C10 H14 N2 O6,258.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,1-(beta-D-ribofuranosyl)thymine,10,14,2,6,0,0,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,14018575.890864663,3361487.073320558,0.2397880568960719,-2.060168290538461,6.535720958670183e-6,3.703143979514427e-5,Downregulated
Feature0030,Leucylproline,C11 H20 N2 O3,228.14735,NA,NA,Leucylproline,11,20,2,3,0,0,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,15232080.996029245,8048794.442698336,0.5284106908830465,-0.920268439188455,0.0010951856327483939,0.0028672346203152954,Downregulated
Feature0029,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,182.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"3,4-Dihydroxyphenylpropionic acid",9,10,0,4,0,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,1111456.4425734505,681650.8700955648,0.6132951719792815,-0.7053465011384408,0.004989908088726866,0.010733009851223824,Downregulated
Feature0028,4-Pyridoxic acid,C8 H9 N O4,183.0532,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,4-Pyridoxic acid,8,9,1,4,0,0,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,6917389.468083585,17391877.044838075,2.5142255073367115,1.3301140545816934,4.608297289333146e-8,8.755764849732977e-7,Upregulated
Feature0027,Succinic anhydride,C4 H4 O3,100.01606,NA,NA,Succinic anhydride,4,4,0,3,0,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,1428609.800175704,907760.0461180579,0.6354149649585302,-0.6542290268422205,0.046167974975643594,0.07378246468070145,Downregulated
Feature0026,"2-(Hydroxymethyl)-5-methoxy-4-methyl-1,3-benzenediol",C9 H12 O4,184.07352,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"2-(Hydroxymethyl)-5-methoxy-4-methyl-1,3-benzenediol",9,12,0,4,0,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,489590.3758226378,193305.5844553734,0.39483125894901483,-1.3406918818268383,0.3478056757668785,0.40459027589208313,Downregulated
Feature0025,100-1,C31 H34 O10,566.21508,Biosynthesis of secondary metabolites;Other,NA,100-1,31,34,0,10,0,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,84254.7292494017,78079.81363842844,0.9267113470545382,-0.10980805811045614,0.6803424403797549,0.7203625839315052,Downregulated
Feature0024,2-Oxo-4-pentenoic acid,C5 H6 O3,114.03175,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,2-Oxo-4-pentenoic acid,5,6,0,3,0,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,43952076.294232,448677.8770067084,0.010208343150914808,-6.614107458909395,2.0903713463058418e-8,4.468168752728737e-7,Downregulated
Feature0023,2-Hydroxycaproic acid,C6 H12 O3,132.0787,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,2-Hydroxycaproic acid,6,12,0,3,0,0,0,0,2,0.5,-1,88.8,1,-2,-0.6666666666666666,-0.1111111111111111,-2,Protein,5472725.812410378,4862236.204871588,0.8884487130427042,-0.17063959783942123,0.6528034638855018,0.6976837020276301,Downregulated
Feature0022,Caffeic acid,C9 H8 O4,180.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Caffeic acid,9,8,0,4,0,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,2830300.9539677207,9963230.493786586,3.5202017933179186,1.815658132804213,7.952265136669023e-6,4.29379708122495e-5,Upregulated
Feature0021,NA,C6 H15 N O9,245.07472,NA,NA,Feature0021,6,15,1,9,0,0,0,0,2.5,1.5,1,31.799999999999997,0,-9,2.5,-11,-10,Carbohydrate,2871322.570531529,17816521.93059206,6.204987942993089,2.633428407035571,0.0010982682317581978,0.0028672346203152954,Upregulated
Feature0020,NA,C27 H24 N6 O8,560.16569,NA,NA,Feature0020,27,24,6,8,0,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Lignin,165058.55576234774,137035.35186550795,0.8302226517891762,-0.2684297999271806,0.18137515731564774,0.24042753411609116,Downregulated
Feature0019,4-Methylphenol,C7 H8 O,108.05753,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,4-Methylphenol,7,8,0,1,0,0,0,0,1.1428571428571428,0.14285714285714285,-0.8571428571428568,84.72857142857141,4,3,0.5,0.5384615384615384,3,Lignin,1082198.654862616,8141200.207409261,7.522833419565448,2.911276144675095,0.00590272661421834,0.012309344524772392,Upregulated
Feature0018,NA,C10 H3 N2 O4 P,245.98313,NA,NA,Feature0018,10,3,2,4,0,1,0,0,0.3,0.4,0.6000000000000001,43.2,11,7,1.3333333333333333,1.2,4,Condensed HC,871302.4132886564,12215889.661995515,14.020263774878902,3.809441587112497,5.4318231055182424e-5,2.2934364223299247e-4,Upregulated
Feature0017,Dimethyl phthalate,C10 H10 O4,194.058,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Other,Dimethyl phthalate,10,10,0,4,0,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,916416.1212588539,306762.3494883755,0.3347413280628292,-1.5788814138644582,0.22802349180248452,0.2942793743262253,Downregulated
Feature0016,Polygonolide,C12 H12 O4,220.07345,NA,NA,Polygonolide,12,12,0,4,0,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,7,3,0.375,0.5,3,Lignin,1322804.282395834,156162.21240564136,0.11805390599643643,-3.082482318729841,0.30624744038579427,0.3700940799008538,Downregulated
Feature0015,Ethylmalonic acid,C5 H8 O4,132.04231,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of L-lysine degradation;Other,Ethylmalonic acid,5,8,0,4,0,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,3155434.4081354025,3463413.328390767,1.0976027007442548,0.1343559365008679,0.9222465413869516,0.927671521042169,Upregulated
Feature0014,[3-(4-Methoxyphenyl)-2-oxiranyl]methyl hydrogen sulfate,C10 H12 O6 S,260.03538,NA,NA,[3-(4-Methoxyphenyl)-2-oxiranyl]methyl hydrogen sulfate,10,12,0,6,1,0,0,0,1.2,0.6,0.20000000000000015,54.599999999999994,5,-1,-0.6666666666666666,0.16666666666666666,-2,Lignin,63168.059569059966,18000359.940449633,284.95983671574265,8.154614784651375,5.134801973238314e-8,8.780511374237517e-7,Upregulated
Feature0013,NA,C10 H16 O8,264.08464,NA,NA,Feature0013,10,16,0,8,0,0,0,0,1.6,0.8,0,60.3,3,-5,-2.5,-0.16666666666666666,-5,Carbohydrate,40121428.55390397,172015.7602282602,0.0042873787506632136,-7.865688412977889,1.7967952041178785e-8,4.0966930653887634e-7,Downregulated
Feature0012,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,NA,.alpha.-Glucoheptitol-peak1,7,16,0,7,0,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,1200936.8186757532,8914777.982455095,7.423186502255153,2.892038615978929,2.6759856871361897e-4,9.151871050005768e-4,Upregulated
Feature0011,2-Oxobutyric acid,C4 H6 O3,102.03169,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,2-Oxobutyric acid-peak2,4,6,0,3,0,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,35329234.101403505,1212926.4618145968,0.03433209048158821,-4.864298484078781,3.120303492963474e-7,3.679806188253476e-6,Downregulated
Feature0010,2-Hydroxyvaleric acid,C5 H10 O3,118.06305,Metabolic pathways;Other,NA,2-Hydroxyvaleric acid,5,10,0,3,0,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,7388587.105493742,7570582.13401288,1.0246319121532472,0.03510573033111121,0.9261426376421382,0.928858598456338,Upregulated
Feature0009,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,0,6,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,3568332.638490873,68527.31406585463,0.019204295397425828,-5.702427157188612,0.32872230891224596,0.38925772662004676,Downregulated
Feature0008,"Î±,Î±-Trehalose",C12 H22 O11,342.11636,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak1",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,1322458674.5718522,6606067.837590709,0.004995292453829934,-7.645215140310259,3.683702285757656e-6,2.377030531564374e-5,Downregulated
Feature0007,Cytidine,C9 H13 N3 O5,243.08554,Metabolic pathways;ABC transporters;Other,Other,Cytidine,9,13,3,5,0,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Lignin,18956976.96276462,586678.7051663218,0.030947904105104878,-5.014014481128654,2.884016838877731e-6,1.933987762541537e-5,Downregulated
Feature0006,D-(â)-Erythrose,C4 H8 O4,120.04223,NA,NA,D-(â)-Erythrose-peak1,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,1810944815.6102488,101736378.23871937,0.05617861867559804,-4.153835037976207,1.6799199712745083e-8,4.0966930653887634e-7,Downregulated
Feature0005,Thymidine,C10 H14 N2 O5,242.09031,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Thymidine,10,14,2,5,0,0,0,0,1.4,0.5,0.20000000000000015,54.599999999999994,5,0,-0.6666666666666666,0.09090909090909093,-2,Lignin,145870871.92268267,36792136.97578749,0.2522240149170341,-1.9872224498624596,1.7633166293637608e-6,1.2563630984216796e-5,Downregulated
Feature0004,2-Oxobutyric acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,2-Oxobutyric acid-peak1,4,6,0,3,0,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,426387588.62827754,1663147.6799156708,0.0039005536846561314,-8.002105355197424,1.0646644160885746e-8,3.0342935858524377e-7,Downregulated
Feature0003,NA,C9 H16 O7,236.0896,NA,NA,Feature0003,9,16,0,7,0,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,352779779.9006125,95378256.37732254,0.27036202699653916,-1.8870355590617762,9.011334228924274e-8,1.284115127621709e-6,Downregulated
Feature0002,L-Iditol,C6 H14 O6,182.079,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak1,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,36084023.6298873,8519260.279150352,0.23609507538660707,-2.0825601456097393,5.017596624524422e-7,5.0471118987863304e-6,Downregulated
Feature0001,"L-Fucono-1,5-lactone",C6 H10 O5,162.05279,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,"L-Fucono-1,5-lactone",6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,25388918.48221952,15858223.524637867,0.6246120147159386,-0.6789677743210768,0.0017371698333712745,0.004274187647575366,Downregulated
